Final Exam Student Questions Flashcards

1
Q

Which of the following is true regarding the development of depression?

A. A family history of Major Depressive Disorder does not affect an individual’s risk for experiencing depression.
B. Most people who suffer from depression suffer from one single episode.
C. Depression develops as a result of a multifactorial interplay of genetics, environment, physiologic, social, and biochemical factors.
D. Depression appears the same in all individuals diagnosed.

A

Answer and rationale: C. The development of depression occurs as a result of the complex interactions between many different factors, including genes, environment, biochemical interactions, social factors and physiologic factors. A is incorrect because a family history does affect, and increase, and individual’s risk for experiencing depression. B is incorrect because most people who suffer from depression have repeated episodes. D is incorrect because depression presents differently with different signs, symptoms, and patterns in different individuals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Which hormone is most involved in the pathophysiology of Major Depressive Disorder?

A. Thyroid hormone B. Estrogen C. Growth hormone D. Dopamine

A

Answer and rationale: D. Dopamine is the hormone most involved in the pathophysiology of depression,
and it is targeted in many of the drug formulations used to manage symptoms in patients that are diagnosed. A, B, and C are incorrect because they are hormones not involved in the pathophysiology of MDD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. During drug therapy for Major Depressive Disorder it is important to maintain regular contact with the patient during which of the following phases:

A. Acute treatment phase B. Continuation phase C. Maintenance phase D. All of the above

A

Answer and rationale: D. All of the above: Antidepressant therapy consists of 3 major phases: acute, continuation, and maintenance. Typically, patients should maintain contact with practitioners during all 3 phases of drug therapy. The practitioner should continue to monitor efficacy, side effects, and adherence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. How long should practitioners recommend antidepressant therapy for a first episode of depression?

A. Only until symptoms resolve B. Indefinitely C. 4 to 6 months after symptom resolution D. PRN for symptoms

A

Answer: (C) Rationale: The practitioner should continue antidepressant therapy 4-6 months after symptom resolution. Failure to continue medication beyond symptom resolution confers an increased risk of relapse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. MAOIs should not be prescribed with SSRIs or SNRIs because of what potential complication?

A- Hyperpyretic crisis B- Neuroleptic Malignant Syndrome C- Serotonin Syndrome D- Myocardial Infarction

A

Answer: (C) Rationale: The combination of MAOIs and SSRIs cause there to be to much serotonin
released or to remain in the central nervous systems, causing a adverse reaction. The most likely cause of serotonin syndrome is usually when two medications that affect the body’s level of serotonin are taken concurrently. A,B and D are all incorrect, as they are not potential complications associated with prescribing MAOIs with SSRIs or SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Which one of these is not a type of depression?

A. Postpartum depression B. Seasonal affective disorder. C. Major depression with melancholic features. D. Insomnia

A

Answer: D. Insomnia. Rational: Insomnia is a problem falling asleep at anytime
A. Is a type of depression that usually happens after child birth
B. Associated with a pattern of depressed or manic episodes that occur with the onset of winter. C. It is characterized by profoundly depressed mood, nonractivity, and neurovegetative symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Patient has been receiving an antipsychotic medication called Haloperidol (haldol). On day 3 of treatment, the patient started having symptoms of shifting weight from foot to foot, walking in spot and inability to keep legs still. What acute condition is patient experiencing?

A. Agitation B. Tardive Dyskinesia C. Perioral MovementsD. Akathisia

A

D. Akathisa because this is an acute condition after receiving antipsychotic medication that can happen and can show signs of to much medication in patients system possibly related to an imbalance between the dopaminergic/cholinergic and dopaminergic/serotonergic system.B,C. Are Tardive responses from adverse effects that can happen with antipsychotic medications. A. Agitation can be commonly confused with Akathisia and increased doses of antipsychotics will make these symptoms worse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A patient has been receiving antipsychotic’s for 5 days now. The patient started experiencing Acute dystonia. Signs/symptoms of this condition is?

A. chest tightness, tachycardia, sweating, worrying B. pin rolling of fingers, loss of swing in arms while ambulating
C. Difficulty swallowing, speakingD. painful movements, face, neck, back, tongue.
Ans Rationale

A

A. is s/s of anxiety. B. is s/s of parkinsonism C. is s/s of tardive dyskinesia
D. results lead to dominant mechanism resulting in acute dystonic reactions is thought to be nigrostriatal dopamine D2 receptor blockade, which leads to an
excess of striatal cholinergic output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

You are the nurse practitioner caring for a patient with major depressive disorder. Your patient’s symptoms have improved on the 20 mg daily dose of Celexa (SSRI) but when you are conducting your 6 month follow up visit, you learn the patient had seen an additional provider and been prescribed Nardil (MAO inhibitor) and the patient has been taking this medication in addition to the SSRI. The patient is now complaining of symptoms consistent with Serotonin Syndrome. All of the following are present in Serotonin Syndrome EXCEPT:

A. Heat stroke B. Fever
C. Increased creatinine
D. Tachycardia

A

A, B, and D are signs and symptoms of the life threatening syndrome in which interactions of
SSRIs and MAO inhibitors leads to sudden increase in systemic serotonin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. The NP recognizes that the patient is experiencing Neuroleptic Malignant Syndrome if

A. The patient has involuntary buccolingual movements B. The patient has a temperature of 98.6 degrees Fahrenheit, bradycardia and warm, dry skin C. The patient has a temperature of 105 degrees Fahrenheit, muscular rigidity, altered mental status, and autonomic dysfunction D. The patient has a shuffling gait and exhibits pill rolling and cog wheeling motions

A

C is correct, a patient with Neuroleptic Malignant Syndrome exhibits fever up to 107 degrees Fahrenheit, muscle rigidity, altered mental status, and autonomic dysfunction. A is incorrect, the patient has tardive dyskinesia. B is incorrect, the patient with Neuroleptic Malignant Syndrome is expected to have high fever, tachycardia and diaphoresis. D is incorrect, the patient is exhibiting parkinsonism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In a teenage patient diagnosed with ADHD with no significant medical history (unremarkable pulmonary and cardiac history and no other mental health diagnoses). In addition to referral to CBT, in which order would you try medication therapy if the patient was not responding to the treatment?

A. First try a stimulant therapy, if no response, try a non-stimulant therapy B. First try a non-stimulant therapy, if no response, try a stimulant and immediately
refer to a mental health specialist
C. First try a stimulant therapy, if no response, try dose increase, if no response, try a
different stimulant therapy, if no response, refer to a mental health specialist
D. First try a non-stimulant therapy, if no response, try dose increase, if no response, try a
stimulant therapy, if no response, refer to a mental health specialist

A

A. Incorrect. A dose increase of the first stimulant should be trialed if the patient does
not experience symptoms with the first intervention. B. Incorrect. A stimulant medication should be tried as first line therapy. Correct answer: C. According to video by Professor Alice Teall the correct order of
treatment for ADHD in the primary care setting is stimulant therapy→ dose increase of first stimulant therapy→ different stimulant therapy→ refer to mental health specialist.
D. Incorrect. A stimulant medication should be tried as first line therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which of the following drug classes would be considered a first line therapy for generalized
anxiety disorder?

A. SNRI B. MAOI C. Benzodiazepine D. Atypical antipsychotic

A

A. SSRI or SNRI are considered first line treatments for GAD in adults
according to Uptodate.
B. MAOI have been found to be effective in the treatment of panic disorders; their effectiveness in treatment of GAD has not been explored. (Arcangelo, Peterson, Wilbur, & Reinhold, 2017) C. According to Uptodate, Benzodiazepines should only be used in treatment resistant or partial treatment resistant GAD. D. Atypical antipsychotics are not indicated in the treatment of GAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which of the following is not part of the clinical features of the movement pattern in tardive
dyskinesia?

A. Repetitive movementsB. Stereotyped movementsC. Abnormal movementD. Painful movements

A

Answer is D. Painful movements
Rationale: Tardive dyskinesia is a neurological syndrome characterized by repetitive, involuntary, purposeless movements caused by the long-term use of certain drugs. Features may include grimacing; tongue protrusion; lip smacking, puckering, and pursing; and rapid eye blinking. Rapid movements of the arms, legs, and trunk may also
occur. Painful movement is not its feature. Ref: medicinenet.com

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antipsychotics are FDA approved for the use of treating behavioral and neuropsychiatric symptoms with the following conditions EXCEPT

A. SchizophreniaB. Alzheimer’s diseaseC. Major depressive disorderD. Bipolar disorder

A

B. Alzheimer’s disease
Rationale: Antipsychotics are not specifically FDA approved for Alzheimer’s and dementia, but they are often widely used for treating patient’s behavioral and
neuropsychiatric symptoms in long term care facilities. Antipsychotics are approved for use with schizophrenia, MDD, and bipolar disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Use of antipsychotics increase risks for falls due to

A. Extrapyramidal side effectsB. Orthostatic hypotensionC. SedationD. All of the above

A

Answer: D
Rationale: Antipsychotics increase risks for falls due to sedation, cardiovascular effects that cause orthostatic hypotension, and extrapyramidal side effects, such as tardive
dyskinesia, dystonia and tremors.Ref: Textbook, page 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Due to the increased risk for agranulocytosis, which antipsychotic is considered a last resort
in treatment resistant schizophrenia?

A. Risperidone B. Quietiapine C. Clozapine D. Aripiprazole

A

Answer: C
Rationale: Clozapine is often considered to be the most effective atypical antipsychotic, but is reserved for resistant cases only due to this potentially fatal ADE. Close blood monitoring is required when a patient is on this drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A client is about to be discharged with a prescription for the antipsychotic agent haloperidol (Haldol), 10 mg by mouth twice per day. During a discharge teaching session, the nurse should
provide which instruction to the client?

A) Take the medication 1 hour before a meal.B) Decrease the dosage if signs of illness decrease C) Apply a sunscreen before being exposed to the sun.D) Increase the dosage up to 50 mg twice per day if signs of illness don’t decrease.

A

C) Apply a sunscreen before being exposed to the sun.

Because haloperidol can cause photosensitivity and precipitate severe sunburn, the nurse should instruct the client to apply a sunscreen before exposure to the sun. The nurse also should teach the client to take haloperidol with meals — not 1 hour before — and should instruct the client not to decrease or increase the dosage unless the physician orders it.Ref: Medscape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Choose the option that covers the clinical signs and symptoms of neuroleptic malignant
syndrome:

A. Hypothermia, dystonia, mental status changes, acute renal failureB. Hyperthermia, rigidity, mental status changes, acute renal failureC. Hypothermia, akathesia, elevated pulse, diaphoresis, renal failureD. Hyperthermia, tardive dyskinesia, diaphoresis, mental status changes

A

Answer is B. Hyperthermia, rigidity, mental status changes, acute renal failure
Rationale: Cardinal features of NMS are severe muscular rigidity; hyperthermia (temperature >38°C); autonomic instability and changes in the level of consciousness. It also includes elevated pulse, diaphoresis and acute renal failure. Akathesia, Dystonia, or tardive dyskinesia
are features of EPS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which is NOT a mechanism of action of antidepressant agents?

a. Inhibits the breakdown of catecholamine’s which increases catecholamines in
synapse. b. Stimulates the post-synaptic receptors. c. Inhibits the re-uptake of catecholamine’s by the pre-synaptic neurons.
d. Potentiate the action of GABA and depress CNS functioning.

A

Explanation: “A” is a MOA of antidepressants because MOAIs inhibit the breakdown of catecholamine. “B” is a MOA of antidepressants because some novel drugs stimulate the post-synaptic receptors. “C” is a MOA of antidepressants because
SSRIs, SNRIs and other anti-depressant agents inhibit the re-uptake of
catecholamines. “D” is the “correct” answer (NOT a MOA) because benzodiazepines
potentiate the action of GABA and are NOT used to treat depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nancy is a 19 year old being treated with SSRI for major depressive disorder. What is a
sign that require immediate intervention by the clinician?

a. Nancy reports an improved mood. b. Nancy reports that the medication is making her restless and she is having trouble
sleeping.
c. Nancy reports that she has started giving away her possessions.
d. Nancy reports nausea and GI disturbances.

A

Explanation: “A” is a positive therapeutic effect of SSRIs. “B” and “D” are negative side effects of SSRI and medication may need to be re-evaluated. “C” is a warning sign of suicidal ideation the “best” answer for this question because it requires immediate intervention.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Brittany is a 30 year old woman diagnosed with major depressive disorder and is started on an SSRI. Which of the following is not an important fact for the clinician to teach the
patient:

a. With the SSRI’s there is a possibility of sexual dysfunction. b. If you begin experiencing signs of serotonin syndrome (fever, tachycardia, profuse sweating, tremors) you should seek medical help right away.
c. You should expect to feel less depressed within a day or two.
d. You should return to the office in 2-4 weeks so we can discuss effectiveness of treatment.

A

Explanation: “C” is the correct answer, as it is not true and should not be taught to patients. SSRIs may take 4 weeks, even up to 12 weeks to take full therapeutic effect. “A” is true, as sexual dysfunction is a commonly reported side effect of SSRIs. “B” is also an important teaching point. Serotonin syndrome is a rare, but life threatening reaction to SSRIs, and the patient should know to seek help right away with these symptoms. “D” is true, as the patient should expect to follow up to make sure therapy is effective and to discuss any side effects that may cause the patient to want to stop treatment. Adjustments to treatment should be made instead.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

According to the Texas Mediation Algorithm what is stage 2 therapy for the treatment of depression?

a. ECT b. Alternate monotherapy SSRI, bupropion, nefazodone, TCA, venlafaxine, MAOI drug,
or combination antidepressant: TCA+ SSRI.
c. Alternate monotherapy SSRI, bupropion, nefazodone, TCA, or venlafaxine.
d. Other

A

Explanation: The correct answer is (C). The recommended treatment for depression according to the Texas Medication algorithm states that stage 2 therapy should be an alternate to the initial monotherapy if the initial treatment does not warrant a beneficial response. Answer (A) is stage 4 treatment if other options have been exhausted with no positive results. Answer (B) is stage 3 treatment per the algorithm and answer (D) is the final stage (stage 5) when all other options have been exhausted with no benefit to the patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Matthew is a 17-year-old high school student who was recently seen in the clinic for feelings of depression. He was brought in by his mother, who noted recent changes in his mood, insomnia, weight loss, difficulty concentrating in school with slipping grades, and overall anhedonia. Matthew told his mom two weeks ago he wanted to quit basketball, a sport he has play his he was five. During his visit, Matthew told the PCP he had been having thoughts of suicide. To ensure Matthew’s safety, his mother was made aware and referrals were made to psychiatry. Matthew has been getting counseling for 2 weeks, and was started on an SSRI 7 days ago. Which finding below is most concerning and requires immediate intervention from Matthew’s mom?

a. Matthew states his mood is “not really better” and still has difficulty concentrating
and intervals of irritability. b. Matthew complains of feeling drowsy at school the first few days after taking the medication. c. Matthew becomes agitated easily, especially when friends or family ask him why he wants to quit basketball.
d. Matthew’s mother notes around day 7 of his medication therapy that Matthew
has more energy, seems less fatigued, and is cleaning his room, even though his mood and depressed affect do not seem improved.

A

Explanation: Answer (A) is incorrect because the typical onset of SSRIs is between 1-4 weeks, so effects of the medication are not likely to be seen on day 7 of the medication therapy. Answer (B) is incorrect because drowsiness is an expected and common side effect associated with SSRIs; for Matthew, the PCP could suggest he take his dose at bedtime, allowing for the drowsiness to take effect during the HS period and hopefully, improving his previous complaints of insomnia. Answer (C) is incorrect because although agitated behavior can be a warning sign of suicide,
agitation can also be a side effect associated with SSRIs. In Matthew’s case, he
becomes agitated specifically when asked about quitting the basketball team, a sport he used to find pleasure playing. With his previous thoughts of suicide, he may be
quitting basketball to end ties with outstanding groups. Answer (D) is the “correct”
answer. With both SSRIs and SNRIs, patients may see an early improvement in symptoms of fatigue and find more energy to get up and act without an improvement in mood or depression due to the 1-4-week onset/full medication effect. With someone who is or has had suicidal thoughts of may have a plan, he or she is at high risk of acting on suicidal thoughts due to a depressive mood but an increase in energy to act.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sally was recently started on an MOAI for major depressive disorder. Which of the following is an important teaching point to include with this class of drugs?

a. MAOIs often cause a benign rash b. Sally should come back to the office is she does not experience relief of symptoms within 7 days c. foods such as aged cheese, tap beer, and yogurt should be avoided when taking MAOI’s
d. MAOIs can be discontinued at any time without risk for side effects

A

Explanation: Correct answer is C–when taken in combination with foods that contain high levels of tyramine, MAOIs can cause hypertensive crisis. Choice A is incorrect because a benign rash is not a common side effect of MAOIs. Choice B is incorrect because it may take up to 4 weeks before Sally experiences relief of symptoms. Choice D is incorrect; Sally should be counseled on the risk of withdrawal symptoms when abruptly discontinuing anti-depressants such as MAOIs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Before starting drug therapy for osteoarthritis, the practitioner should recommend appropriate nonpharmacologic therapies. These recommendations should include all the following EXCEPT:

a. Moist heat to help diminish muscle spasms and relieve stiffness b. Weight loss, especially for patients with hip and knee osteoarthritis c. Avoid exercise which can deteriorate the joints that have osteoarthritis d. Use of assistive devices to help with ambulation and ADLs

A

Rationale: C is the answer. According to our text, A, B, and D are good recommendations for
nonpharmacologic therapies. C is incorrect because exercise can strengthen muscles surrounding the involved joints and a fitness program can maintain flexibility of the involved joint through swimming, walking, cycling, or isometric exercises (p. 593 of the textbook)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Due to the cost effectiveness, safety, and few adverse events (dizziness and rash) if taken within recommended dosage, this is the first line pharmacotherapy for osteoarthritic pain:

a. Corticosteroid Injections b. Acetaminophen c. Analgesics like tramadol d. NSAIDs like aspirin or naproxen

A

Rationale: b. Acetaminophen is the correct answer. If the patient stays within the recommended
dose there are very few side effects, and it is more cost effective. Corticosteroid injections are not the correct answer because they are restricted in use due to the potential for cartilage destruction and osteonecrosis from repeated injections. Analgesics are not the correct answer because you can only prescribe them for a limited time due to potential dependence and withdrawal symptoms. NSAIDS are not the correct answer because they have the possibility for many adverse events including visual changes, weight gain, headache, dizziness, nervousness, photosensitivity, weakness, tinnitus, easy bruising or bleeding, and fluid retention. (p. 593 - 599 in the text)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

A 60-year-old woman comes into the office and is diagnosed with osteoarthritis in her hand along with nonpharmacological you prescribe capsaicin, a topical agent, you tell her to expect the topical agent to take effect in what amount of time?

a. 2 to 4 weeks b. 1-2 hours c. 1 week d. 3-4 days

A

Rationale: A. 2 to 4 weeks is the correct answer, If the patient continuously uses capsaicin the
maximal effect is seen in 2-4 weeks. B is wrong because Analgesics such as Tramadol a decrease in pain is seen in 1-2 hours. C is wrong because this is for acetaminophen, which if it is taken around the clock patients will experience pain relief in 1 week. D is how soon patients that receive corticosteroid injections would have symptom relief.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

The 60-year-old woman who is newly diagnosed with osteoarthritis in her knee ask what her goals of treatment are with this condition. You accurately tell her that the pharmacologic goals in the treatment of osteoarthritis are all the following except:

a. To maintain function b. To prevent further joint damage c. To completely reverse the effects of damage to her affected joint d. To diminish associated pain

A

Rationale: Answer C is the correct answer. Pharmacologic treatment goals for osteoarthritis are to maintain function, prevent further joint damage, and to diminish associated pain (Per Pharmacotherapeutics for Advanced Practice textbook and its associated powerpoint slides). Answer C is therefore wrong in the pharmacologic treatment goals because there are no pharmacologics that actually reverse the effects of osteoarthritis to restore that joint to its original, pre osteoarthritic, functioning. Therefore, C would be the correct answer in this scenario.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

A 51-year-old male, David, comes into your office and after a history and physical, you diagnose him with osteoarthritis of his hand. Out of these treatment options, which is not a 1st, 2nd, or 3rd line treatment for OA of the hand?

a. Acetaminophen b. Topical NSAIDs, like capsaicin c. NSAIDs, like ibuprofen d. Opioids

A

Rationale: Answer D is the correct answer. This is because the recommendations for treatment of
OA of the hand include 1st line of topical NSAIDs like capsaicin, 2nd line of APAP (acetaminophen), 3rd line of NSAIDs, and steroids for painful flare ups. All of these would be chosen before the practitioner considers opioids for the pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

When educating a patient on taking acetaminophen for Osteoarthritis, all the following are important
EXCEPT:

a. Acetaminophen should only be taken when pain is present with osteoarthritis. b. Patients should be aware of other products that may contain acetaminophen so that they are not exceeding the daily limit. c. Alcohol should be minimized or avoided. d. Patients with a history of liver disease or who are chronic alcohol drinkers should not take more than 1,800 mg a day.

A

Rationale: Answer A is the correct answer. The key to acetaminophen dosing for OA is to
schedule the dose regarding the patient’s pain. To be most effective, it must be taken regularly. The recommended dose is 650 mg every 4-6 hours or 1,000 mg every 6-8 hours. The patient should not wait until pain is present. It is most effective when taken around the clock to stay on top of the pain. If taken as scheduled, patients may have pain relief within 1 week of initiation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

The Food and Drug Administration (FDA) issued a “black box warning” forestrogen to alert postmenopausal consumers of the increased risk of:

a. Myocardial Infarction b. Stroke c. Breast Cancer d. All of the above -

A

D. Postmenopausal women using estrogen to manage the effects of menopause should be warned that estrogen use is linked to increased risk of heart disease, MI, stroke and breast cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

All of the following are reasons to implement evidence-based guidance for contraceptive use except :

a. To base family planning practices on the best available evidence - This is a reason to implement evidence-based guidance for contraceptive use.
b. To create medical barriers to contraceptive use - Incorrect; evidence-based guidance for contraceptive use works to remove medical barriers. c. To address misconceptions regarding who can safely use contraception - This is a reason to implement evidence-based guidance for contraceptive use. d. To improve access and quality of care in family planning - This is a reason to implement evidence-based guidance for contraceptive use.

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

A 52-year-old woman reports having hot flashes and intense mood swings. After a year of having irregular menstrual periods, she has not had a period for 6 months. The primary care NP should diagnose:

a. Menopause - defined as the absence of menstrual periods for 12 months b. Dysmenorrhea - refers to the symptom of painful menstruation c. Perimenopause - “menopause transition”, correct because she has not been without a period for over a year but is beginning to experience signs
and symptoms of menopause d. Postmenopause - stage following menopause and generally starts between 24 and 36 months after a woman’s last period.

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

A 38-year-old woman visits her gynecologist for birth control. She tells her gynecologist she typically uses condoms but would like something that her and her partner do not have to deal with at the time of intercourse. She notes that she smokes 3 cigarettes/day and has a history of a deep vein thrombosis. All of the following are appropriate choices for the gynecologist to offer the patient except :

a. Depo-Provera - This form of birth control is safe for women older than 35 years of age who smoke and have a history of an embolic event. b. Implanon - This form of birth control is safe for women older than 35 years
of age who smoke and have a history of an embolic event. c. IUD - This form of birth control is safe for women older than 35 years of age who smoke and have a history of an embolic event. d. Combined oral contraceptive - Combined oral contraceptives are contraindicated in patients who are over 35 years old and smoke and who have a history of an embolic event.

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Sara is a 37 year old woman with a history of diabetes mellitus and hypertension. Which contraceptive would be the first choice for her?

a. Seasonale - This is an estrogen-containing contraceptive; this would put Sara at a high risk for VTE. b. Ortho-cyclen - This is an estrogen-containing contraceptive; this would put Sara at a high risk for VTE. c. Plan B - This should be used as emergency contraception only. d. Nexplanon - Progestin-only hormonal contraceptives are the best choice for women at increased risk of VTE (ex: hypertension, smoking, migraine headaches, diabetes, over age 35.

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

When taking a daily oral contraceptive, a patient should be told to contact the provider for all the following reasons EXCEPT ?

a. Experiencing ear pain - A patient is advised to contact the provider immediately if they experience chest pain, eye pain/problems, severe leg pain, severe abdominal pain, and headaches. These could be symptoms of other life threatening problems occurring in the patient such as DVT,
stroke, HTN, MI, PE, or gallbladder disease b. Experiencing chest pain c. Experiencing severe leg pain d. Experience abdominal pain

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

J. N., 23-year-old graduate student at a business college, presents to the family practice clinic for seeking a hormonal oral contraceptive (OC) since she is dating her boyfriend for 3 months. But like many women, she is unaware of the health risks and side effects of OC. As a healthcare practitioner, what the potential side effects that need to be explained to J.N. that she must seek immediate medical care except

A. Headache B. Severe leg pain C. Chest pain
D. Depression

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

A.B. is a 26-year-old woman who identifies as a lesbian and has sex with women. She returns to your clinic for a follow-up appointment following a diagnostic laparoscopy that revealed endometriosis. After recommending a
contraceptive, A.B. asks “why do I need to take birth control if my partners are
women?” You respond by saying:

A. “The copper ions of a nonhormonal IUD will alter the uterine pH, creating an
environment that will limit endometrial proliferation and inflammation. This will
ease your endometriosis symptoms.”B. “A triphasic oral contraceptive will mimic your body’s natural hormone
fluctuations throughout the menstrual cycle. Taking this medication will ensure your endometriosis symptoms are more predictable and manageable through other pharmacotherapies.”
C. “Monophasic continuous hormone therapy through oral contraceptives will regulate the hormone levels that otherwise cause negative symptoms of your endometriosis. Taking one pill per day every day will reduce your symptoms.”
D. “We suggest folks with a new diagnosis of endometriosis take a contraceptive in the time leading up to surgical treatment to prevent an unintended pregnancy. You may not need this medication if your partners don’t have sperm.”

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

H.M. is an 18 year old female presenting to your clinic. She informs you that she is sexually active with men and will be attending college next year, which is why she wanted to begin taking an oral contraceptive. As her provider, you also inform H.M. of other contraceptive methods in addition to providing information regarding oral contraceptives. What information is important to include?

A. She may want to consider using a different method, because oral contraceptives can have high failure rates in teens and young adults
B. She may want to consider using the Ortho Erva patch for contraception because
it also protects against STIs C. She may not want to consider using the Nuva Ring since it must be inserted into the vagina every two weeks D. She may want to consider using the Depo Provera shot because she would only need to receive the injection once a year while on summer break

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

A 25 year old female is interested in starting Depo Provera injections as a form of contraception. She asks, “What do I need know about it?” You replied the
following statements except:

A. “Depo Provera is injected intra-muscularly every 11 to 13 weeks.”B. “Depo Provera can cause possible weight gain and particularly bone loss; so
exercise regularly and increase taking calcium and Vitamin D.”
C. “If you come later than 13 weeks, I will give you Depo Provera injection right away.”
D. “Return to fertility is around 10 months from the last injection.”

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

K.L. a 21 year old college student has come to your clinic in need of
contraception and would like to know what the benefits of oral contraceptives are. You inform her that the benefits are:

A. She will be protected from STI’s, including HIV with oral contraceptive
use. B. Weight gain is not a factor to consider with oral contraceptive use and this method also alleviates breast tenderness. C. Oral contraceptives help regulate menses and decrease the risk of ovarian and endometrial cancer.D. Oral contraceptive dosing is convenient and easy to remember. You only need to take it once a week.

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

M.L. is a 30 year old female and is an established client at your clinic. Today she presents to refill her oral contraception prescription. When reviewing her medication history she informs you that she is has been taking an antibiotic for the last 3 days, and still has 7 days left of the regimen for a recent infection. Is this of any concern to you as a provider when refilling her prescription?

A. No, oral contraceptives have low drug-drug interactions B. No, she is an established client who you know has been healthy during past visits C. Yes, she cannot take her contraceptive during the antibiotic regimen because it will further increase her risk for thromboembolic disease D. Yes, she should continue to take her oral contraceptive, but it is important to educate her that the antibiotics can decrease the contraceptive effectiveness

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

You are an NP counseling your 22 year old patient about contraceptive options. She is interested in using Mirena but wanted to know how it works. You respond:

a. It inhibits sperm motility by creating an inflammatory reaction in the uterus to prevent sperm from reaching the tube b. It uses progestin only to causes cervical mucus to thicken, preventing sperm from reaching an egg, and it occasionally prevents an egg from being released c. It kills sperm and is a physical barrier to sperm entering the cervix d. It uses both estrogen and progestin to suppress ovulation

A

A. INCORRECT. The mirena does not cause an inflammatory reaction. This is an IUD but it is describing how the Paragard works. B. CORRECT. Mirena is a progestin only treatment that only partially inhibits ovulation but does prevent the sperm from moving into the reproductive system. C. INCORRECT. This is describing a cervical cap or diaphragm what are used with spermicide and create a physical barrier D. INCORRECT. The mirena is a progestin only treatment. This answer describes multiple other OC like pills, the patch or the nuva ring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

JY, a 25 year-old female, was on vacation and forgot to take two doses worth of her daily oral contraceptive medication. Her oral pills were 20mg doses and this was first week of her scheduled doses. Her and her boyfriend had intercourse the previous night. According to oral contraceptive guidelines, what should be her next action regarding the missed
doses? Please select one answer.

a. She should take missed pill as soon as possible and resume schedule; a back-up plan of contraception is not necessary. b. Use condom or abstain from sex for 7 days c. Finish the active pills in the pack and start a new pack the next week d. Use Levonorgestrel and resume taking the pills the next day after using Levonorgestrel

A

Answer: D Rationale: If a woman missed two doses and is in her first week of her medication cycle and has had
intercourse, she should use emergency contraception a soon as possible, but could use it effectively up to 120 hours after intercourse. She should then resume her scheduled medications as before.
A- This answer would be suitable for missing a single dose or if she had missed two doses of 30-35mg pills at any point into the cycle. B- This answer would be suitable if she missed more than two doses of any mg or two 20mg doses as a preventive measure while she begins taking the medication as originally planned. C- This answer is more suitable for someone who missed more than two pills or missed two pills of 20mg doses in their third week of medication cycle without intercourse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

After discussing different contraception options, your patient decides to try The Patch (Ortho Evra). The education on The Patch includes all of the following except:

a. Avoid placing the patch on exactly the same site two consecutive weeks b. Location of patch should not be altered mid-week c. Placing lotion/creams/powders on site will not interfere with the patch
d. Never place patch on the breast

A

Correct answer is : C; an NP should educate patient to avoid placing lotion/creams/powders on site and place patch on clean and dry skin.
A is incorrect: Education should include to avoid placing patch on the same site two consecutive weeks.
B is incorrect: Education should include that the location of patch should not be altered mid-week, but should be applied the same day each week.
D is incorrect: Education should include that the patch should never be placed on the breast, cut or irritated skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

A 28 year old patient sees an NP in clinic. She is 3 months postpartum and is breastfeeding. She is interested in oral contraception. NP understands that the recommended oral contraceptive agent for breastfeeding postpartum patient is which of the following?

a. Progesterone only mini pill b. monophasic continuous therapy c. Combination pill with higher estrogen content in first half of cycle d. Depot medroxyprogesterone acetate

A

Correct answer is: A; Progesterone-only mini-pill is appropriate for a lactating woman. B Is incorrect because monophasic continuous therapy is the recommended agent for a patient with endometriosis.
C is incorrect because a combination pill with higher estrogen content in first half of cycle is recommended for a patient with breakthrough bleeding in the first half of the cycle. D is incorrect because depot medroxyprogesterone acetate is recommended for a noncompliant patient. ( Text Chapter 55 contraceptive notes power point, slides 16-18)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

An 18 y/o patient comes to see you at the clinic. She is interested in oral contraception. This patient describes herself as being anxious and very worried about cancer since there is a history of different cancers in her family. You are able to tell this patient that an advantage of oral contraception is that it may reduce the risk of which cancer:

A.) Brain cancer B.) Breast cancer C.) Ovarian cancer D.) Cervical cancer

A

The correct Answer is (C). Oral contraceptives. Having given birth, a tubal ligation, ovary removal, hysterectomy, having used birth control for 5 years or more, and breastfeeding are associated with a lower chance of getting ovarian cancer. Answer A is incorrect because there is new research that might suggest a link between use of oral contraceptives and brain tumors and a brain cancer known as glioma. Answer B is incorrect because birth control increases the risk of breast cancer. Answer D is incorrect. Long-term use of oral contraceptives increases the risk of cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

The NP receives a phone call from an 18-year old female patient on combined oral contraceptive pills, stating that she missed the previous two days of her birth control pill. She is inquiring as to what she should do now, as these are the “active pills”. The NP
advices her to:

A. Discard the current pack begin with the new one the following day. B. Resume taking the pills that are scheduled the following day. C. Take two active pills today and two active pills tomorrow, then resume the regular schedule. D. Take the most recent missed active pill as soon as possible, discard other missed pills, and continue with the regular schedule, even if it means taking two pills in one day. Use back-up contraception or avoid intercourse for 7 days.

A

D. Take the most recent missed active pill as soon as possible, discard other missed pills, and continue with the regular schedule, even if it means taking two pills in one day. Use back-up contraception or avoid intercourse for 7 days. A. is INCORRECT because the patient should continue taking her current pack and finish it before starting a new pack. B. is INCORRECT because the patient should take her missed pills as soon as she remembers it on the same day she should take it. C. is INCORRECT because pt should just take the recent pill that she missed and discard other missed pills and continue with the regular schedule. Rationale:
Based on the US selected practice recommendations for contraceptive use, 2016 (CDC)
Recommendations for providers for two missed pills for combined Progestin and Estrogen OCPs: -Missed oral contraceptive pills is a major cause of oral contraception failure.

Guidelines have been established by the Centers for Disease Control and Prevention, which provide recommendations for missed oral contraception. Currently, if two or more pills are forgotten (more than 48 hours late) only the last ‘forgotten’ pill is taken, other missed pills are discarded and the next pill taken at the usual time - often this means taking two pills in one day. -A back-up method (condoms or avoid intercourse) is needed for the next 7 consecutive pill days. -If pills were missed in the last week of hormonal pills (days 15 to 21 for 28 pack days): omit the hormone free interval by finishing the hormonal pills and the current pack and starting a new pack the next day If unable to start a new pack immediately, use a back up contraception until hormonal pills for my new pack of been taken for seven consecutive days -Considered emergency contraception if hormonal pills were missing during the first week and unprotected sexual intercourse occurred in the previous five days or at other times as appropriate -If the patient missed the inactive pills, the pack should be finished in a new pack started the next day missing out the break Source: the American College of Obstetricians and Gynecologists and CDC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Absolute contraindications in hormone therapy include all of the following EXCEPT:

a. Uncontrolled hypertension b. Known or suspected pregnancy c. Diabetes Mellitus d. Acute liver disease

A

C (Diabetes Mellitus)

Rationale: Uncontrolled Hypertension, known or suspected pregnancy, and acute liver disease are all absolute contraindications to hormone therapy (Found in textbook Box 56.1 on page 976). Diabetes Mellitus is not contraindicated in hormone therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Women with low estrogen levels, after menopause, are more likely to report any of the following symptoms EXCEPT:

A. Mood changes B. Vaginal dryness C. Insomnia D. Cold intolerance

A

Answer: D (Cold intolerance)
Rationale: Vaginal dryness, insomnia, and mood changes are all very common symptoms for women who are perimenopausal or postmenopausal. Cold intolerance is not a common symptom, as many women experience hot flashes. Any of these symptoms may indicate a need for hormone replacement therapy for symptom control, but not for prolonged use. (Found in textbook on page 972.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Which of the following statements about the use of Hormone therapy is TRUE?

A. Alcohol decreases the circulating levels of estrogenB. Patients on phenytoin metabolize estrogen at a slower rate
C. Use of hormone therapy containing estrogen plus a progestogen is linked to an increased risk of colon cancerD. An increased dose of estrogen may be needed in smokers

A

Answer: D Rationale: D is correct because an increased dose of estrogen may be needed in smokers because only half of the serum level
achieved in nonsmokers is reached (Textbook pg. 976, Interactions paragraph)
A is incorrect because alcohol increases the circulating levels of estrogen due to the liver’s preoccupation with
metabolizing the alcohol at the expense of estrogen (Textbook pg. 976, Interactions paragraph)
B is incorrect because patients taking phenytoin metabolize estrogen at a faster rate (Textbook pg. 976, Interactions paragraph)
C is incorrect because the use of hormone therapy containing estrogen plus a progestogen in linked to a lowered risk of colon cancer (Textbook pg. 977)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

When providing patient education for individuals starting hormone therapy, which of the following information SHOULD NOT be included:

A. It may take up to 4 weeks for the patient to experience a decrease in symptoms B. Management of menopause is achieved on the highest dose possible for as long as the patient wants C. Patients should be encouraged to talk to their provider about any adverse events D. In the event of a missed dose the patient should not double the next dose

A

Answer: B (Management of menopause is achieved on the highest dose possible for as long as the patient wants)
Rationale: Patients should be advised that management is achieved on the lowest dose and for the shortest duration possible due to increased risk of breast cancer, CHD, and VTE associated with long term use. Patients are encouraged to reach out to their provider when they feel discontinuation is appropriate (Found in textbook pgs 975 & 981).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Clara is a 42 year old female patient who has come to you for her yearly physical exam. She expresses that she is finished having children and is curious about her options for birth control. When choosing birth control option that would work for her, absolute contraindications for combination oral contraceptive pills would include all of the following EXCEPT:

A. Family history of breast cancer B. Liver disease C. Current pregnancy D. Personal history of embolic event

A

Answer: A (Family history of breast cancer)
Rationale: Absolute contraindications for combination oral contraceptive pills include thombophlebitis, thromoembolic disorder, cerebral vascular disease, coronary occlusion, impaired liver function, breast cancer, abnormal vaginal bleeding in the absence of a diagnosed cause, pregnancy, and smokers older than 35 years old. (Found in textbook pg. 967 box 55.2 ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

When deciding which contraceptive agent is most appropriate the practitioner should consider all of the following measurements EXCEPT:

A. Height B. Blood pressure C. Lipid panel D. Body mass

A

Answer: A (height)
Rationale: When selecting the most appropriate contraceptive agent for a patient the practitioner should consider body mass index because the obese patient may require higher doses of estrogen and progesterone. Additionally, baseline blood pressure, lipid panel measurements and liver and renal function panels should be taken into consideration to determine if the patient is an appropriate candidate for oral contraception. Height is not a determining factor of the appropriate agent. (Found on textbook page 966).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

A patient is diabetic and has CKD. Which of the following oral medication is the best for
this patient?

a. Starlix/Nateglinide (a meglitinide analog) b. Metformin (a biguanide) c. Glimepiride (a 2nd generation sulfonylurea) d. Prandin/Repaglinide (a meglitinide analog

A

D
Rationale: According to the text and lecture, metformin (p. 793), glimepiride (p. 792) and
nateglinide (lecture) are contraindicated or use with caution in patients with CKD. Repaglinide is excreted by the liver, not the kidneys, so it is safer to use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

A patient has diabetes, obesity, heart failure, a history of falls, and family history of bladder cancer. Which of the following medications would be the most contraindicated?

a. Thiazolidinediones (Actos, Avandia)b. Alpha-glucose inhibitors (Acarbose) c. Amylinomimetics (Pramlintide) d. Sulfonylureas (Glyburide, Glimepiride)

A

Rationale: According to the text and lecture, thiazolidinediones are contraindicated for patients with heart failure (793-794). These medications also have adverse side effects of weight gain, risk of fracture, and fluid retention. Alpha-glucose inhibitors (794), amylinomimetics (797), and sulfonylureas (788, 792) make no mention of heart failure. According to the lecture, there is a Black Box warning for thiazolidinediones and heart
failure

57
Q

Which drug class may mask symptoms of hypoglycemia in a diabetic patient taking a sulfonylurea?

a. Beta Adrenergic Blockers b. Calcium Channel Blockers c. ACE Inhibitors d. Thiazide and Thiazide-like diuretics

A

Rationale: According to the lecture (Insulin Precautions/Interactions slide) and text (Page
266), Beta blockers (except for metoprolol) may mask the symptoms of hypoglycemia. Hypoglycemia triggers the release of catecholamines which bind to Beta 1 receptors in the heart causing an increase in heart rate. Beta blockers decrease this effect.

58
Q

Mrs. S, a 76-year-old female patient with diabetes mellitus (DM) type II and a new diagnosis of congestive heart failure (CHF), is admitted to the cardiac step-down unit from the ICU. Based on her health history, her admitting diagnosis of community-acquired pneumonia (CAP), and her last labs that show worsening renal insufficiency, which one of her home medications would you avoid restarting?

a. sitagliptin (Januvia) b. melatonin c. metformin (Glucophage)d. rosiglitazone (Avandia)

A

C Rationale: According to the text (pg 793), metformin-induced lactic acidosis is a potentially fatal complication of metformin therapy. Risk of lactic acidosis increases with
age and renal dysfunction, so with Mrs. S’s recent infection most likely contributing to
her renal dysfunction and probable poor tissue perfusion, metformin should not be restarted at this time. In addition, metformin is contraindicated with CHF. (Mackenzie)

59
Q

Which oral diabetic agent is contraindicated when taken in combination with insulin?

a. Dapagliflozin b. Rosiglitazone c. Repaglinide d. Metformin

A

B Rationale: According to the text and lecture, Rosiglitazone is contraindicated in patients already taking insulin. Taking these medications together may pose increased risk of heart issues, such as decreased blood flow to the heart and angina.

60
Q

What are the most important components of an effective DM treatment program?

a. Self-monitoring of blood glucose and reduced sugar intake
b. Individualized drug therapy, oral glucose-lowering agents, prevention and treatment of acute and chronic complications. c. Regular exercise, patient education, high carbohydrate diet d. Periodic assessment of treatment goals, medical nutrition therapy, targeted blood glucose goals

A

B Rationale: According to the lecture, the most important components of an effective
treatment program for DM is to create a drug therapy regimen individualized for each patient, to include oral glucose-lowering agents for some type 2 patients, and to prevent and treat both acute and chronic complications of DM such as hypoglycemia.

61
Q

Short Acting Insulin (Regular Insulin) can be given via which route?

A.) Oral B.) SQ C.) SQ and IV D.) None of the above

A

C Rational: C.) is the right answer because it has both routes that Regular insulin can be
administered. B.) is right as well but isn’t best because IV is also an optional route. A.) is
incorrect because it can not be administered orally and D.) is wrong as well because C.) is right. See Diabetes lecture per L. Cordell specifically the slide titled “Short Acting Insulin”.

62
Q

How often in a 24 hr period should a long acting insulin be given to a Type 1 DM?

A.) 1 B.) 3 C.) 2 D.) 4

A

Rational: A.) is the correct answer based on the recommended treatment for long-acting insulin administration for a Type 1 diabetic. B, C,and D are wrong because this would be too much long acting insulin for a Type 1. See Diabetes lecture per L. Cordell specifically the slide titled
“Recommended order of treatment for Type 1 DM”.

63
Q

Considering peak times, if Lispro (Humalog) was administered at 0700, at what time should you monitor for signs/symptoms of hypoglycemia?

A). 1200 B). 1400 C). 1100 D). 0800

A

Rational: D) is the correct answer because rapid acting insulin peaks 45-75 minutes after
administration. This is the time when the patient will be at highest risk for hypoglycemia. A, B,
and C are outside of the peak time. See Table 46.4, pg. 799 and Professor Cordell’s lecture,
slide 34.

64
Q

Regular insulin (Humulin, Novolin), a short acting insulin, is most appropriate for patients who are:

A. Receiving bolus tube feeding B. Receiving continuous tube feeding C. NPO D. Both B & C

A

Answer choice D is the correct answer because regular insulin therapy is used for patients who are not having prandial spikes throughout the day, and patients on continuous tube feeding and NPO patients will not have prandial spikes. Answer choices B and C are correct for the same reason, but D is a more inclusive answer. Answer choice A is incorrect because every time a patient receives a bolus tube feeding, they will have a prandial spike and rapid acting insulin would be more appropriate in this situation. See Diabetes lecture per L. Cordell specifically the
slide titled “Short Acting Insulin”.

65
Q

Most patients with type II diabetes will eventually require intensification from oral agents to exogenous insulin. This is because:

A. Oral antihyperglycemics become less effective as beta-cell function declines B. Endogenous insulin production declines as age and disease progress C. Oral antihyperglycemics like metformin cause significant weight gain D. Both A and B

A

D Rationale: In patients with DMII, progression of the illness causes worsening insulin resistance and decreased insulin secretion. Because of this, intensification of treatment to include exogenous insulin is often indicated. “Insulin is the preferred second-line medication for patients with A1C >8.5 percent or with symptoms of hyperglycemia despite initial therapy with metformin and lifestyle intervention. Avoiding insulin, the most potent of all hypoglycemic medications, at the expense of poorer glucose control and greater side effects and cost, is not likely to benefit
the patient in the long term.” (McCulloch, 2017)

66
Q

According to the titration algorithm developed by the American Diabetes Association: following initiation of intermediate/long acting insulin therapy, how frequently should dose titration occur in order to achieve target fasting glucose levels (80-130mg/dl)?

A. Every 6 hours after checking fasting glucose levels B. No sooner than one month after initiation C. Every 3 days after checking daily fasting glucose D. Prior to every meal after checking glucose levels

A

Answer: C.
Rationale: Following the initiation of intermediate/long acting insulin therapy, the ADA recommends checking fasting glucose daily and increasing insulin dose by 2 units every 3 days until fasting glucose is within target range (80-130mg/dl).

67
Q

Pramlintide (Symlin) an injectable agent that is a synthetic form of the pancreatic neurohormone amylin can be used in conjunction with insulin and acts by these mechanisms: Select All That Apply:

A.) Delays gastric emptying into the small intestine B.) Altering the release of inappropriate glucagon by pancreatic alpha cells C.) Increases satiety, decreasing total caloric intake and promotes weight loss D.)Promotes gastric emptying E.) A,B,C

A

Correct response: E.
Rationale: Amylin affects glucose control through several mechanisms, including slowed gastric emptying, regulation of postprandial glucagon, and reduction of food intake (table 1). Glucagon-like peptide 1 (GLP-1) exhibits similar properties as amylin, with the exception of insulin secretory effects. Amylin, unlike GLP-1, does not have insulin secretory effects, but both regulate hyperglycemia in part through amelioration of inappropriate glucagon secretion and gastric emptying. GLP-1 and amylin appear to have differing magnitudes of physiologic effects and bind to different receptors in the area postrema, the part of the brain that may be key for their effects on satiety
Pramlintide is a stable, soluble, non aggregating, equipotent amylin analog that is administered by mealtime subcutaneous injection. It is available for use for both type 1 and insulin-treated type 2 diabetes. Pramlintide reproduces the actions of amylin and controls glucose without causing weight gain.

68
Q

The following scenario pertains to questions 1 and 2-
Kasey is a 28 year old woman who presents to your office complaining of pain with urination and white vaginal discharge for almost a month. She states she has had multiple sexual partners in the last few months. She says she sometimes uses condoms for protection and has birth control pills that she usually takes, but is not always very good about using protection during every sexual encounter or taking her birth control pill every day. After an examination and urine culture it is confirmed that Kasey is infected with N. gonorrhea. She states she has NKA to medications.

  1. As her provider, you will treat Kasey for which of the following in addition to her N.
    gonorrhea infectiona. Chlamydiab. Syphilisc. Human papillomavirus
    d. Genital herpe
A

Best answer- a. Chlamydia
Rationale- Patients who are infected with N. gonorrhea are often coinfected with C. trachomatis
(the bacteria that causes chlamydia). In order to prevent spread, serious comorbidities and antimicrobial resistance, patients with gonorrhea are also treated for chlamydia. b. Syphilis, c. HPV and d. Genital herpes are incorrect because they do not as commonly coexist with gonorrhea and are not automatically treated without a confirmation of infection.

69
Q

The best course of treatment for Kasey would be

a. Ceftriaxone 250 mg IM onceb. Ceftriaxone 250 mg IM once PLUS azithromycin 1 g PO oncec. Ceftriaxone 250 mg IM once PLUS doxycycline 100 mg PO bid for 7 days
d. None of these because she might be pregnant

A

Best answer- b. Ceftriaxone 250 mg IM once PLUS azithromycin 1 g PO once
Rationale- This course of treatment is effective at treating both N. gonorrhea and C. trachomatisand can be given in the office during the same visit. This is ideal for the patient because she stated that she does not take her birth control pill daily as indicated, and therefore may not be reliable in continuing to take an ATB bid for 7 days.a.Ceftriaxone 250 mg IM once is incorrect because this alone will not treat for C. trachomatis
c. Ceftriaxone 250 mg IM once PLUS doxycycline 100 mg PO bid for 7 days is incorrect because the patient has stated that she does not take her birth control pill daily and therefore may not be reliable in continuing to take the doxycycline bid for 7 days.
d.None of these because she might be pregnant is incorrect because ceftriaxone and azithromycin are pregnancy category B and can be taken even if she is pregnant.

70
Q

Which of the following is FALSE regarding rational drug selection for Chlamydia?

a. Patients should also be treated for gonorrhea b. All women with multiple sex partners should be screened
c. The preferred treatment is Penicillin
d. All sexually active women younger than 25 should be screened annually

A

Best answer: C. The preferred treatment for Chlamydia is Azithromycin, Erythromycin, Doxycycline, and Ofloxacin.

71
Q

When treating patients for Syphilis, people exposed to which stage should be
evaluated clinically and serologically?

a. Stage I only b. Stage II only c. Latent only d. Stage I and II only
e. Stages I, II and latent

A

Best answer: E. People exposed in any stage of Syphilis should be evaluated.

72
Q

Which of the following statements is NOT true regarding patient education on genital herpes?

a. HSV can still be transmitted during asymptomatic periods, thus use of condoms is highly recommended.
b. Asymptomatic viral shedding is more frequent in genital HSV-1 infections than genital HSV-2 infection and most frequent in the first 12 months of acquiring HSV-1.
c. Effective episodic treatment of recurrent herpes requires initiation of therapy within 1 day of lesion onset or during the prodrome that precedes some outbreaks. d. All persons with genital HSV infection should inform current and future sex partners before initiating a sexual relationship.

A

Except for B, all the above statements are true regarding genital herpes. Asymptomatic viral shedding is actually more frequent in genital HSV-2 infections and the most during the first 12 months of acquiring HSV-1

73
Q

An AIDS patient, who is being treated with multiple drugs, develops breast hypertrophy, central adiposity, hyperlipidemia, insulin resistance and nephrolithiasis. If these changes are related to his drug treatment, this drug belongs to which group of anti-retroviral drugs?

a. Nucleoside Reverse Transcriptase Inhibitors (NRTIS) b. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIS) c. Fusion Inhibitors
d. Protease Inhibitors
e. Integrase Inhibitors

A

Best answer: D. Protease inhibitors can cause a syndrome of lipodystrophy, hyperlipidemia, diabetes mellitus type 2, and kidney stones.

74
Q

Jane presents to the clinic with vaginal discharge. The culture is positive for chlamydia trachomatis. Jane has a history of non-compliance with medications. What is the best option for her treatment?

a. azithromycin 1g PO once b. doxycycline 100 mg PO bid for 7 days c. erythromycin base 500 mg qid for 7 days d. ceftriaxone 250 mg IM once

A

Answer: A
Rationale: While A,B,C are all appropriate treatments for Jane’s chlamydial infection, due to her history of non-compliance the best treatment for her is the single dose of azithromycin. Ceftriaxone is not an antibiotic indicated for chlamydia, this is generally indicated for PID (UpToDate, 2017).

75
Q

After Jessica has been prescribed azithromycin PO once for her chlamydial infection she asks her Nurse Practitioner if there is anything important she needs to know. Which one of these are NOT correct.

a. Jessica should refer any partner within the last 60 days for treatment.
b. Jessica should abstain from sexual intercourse for 7 days after her single dose
treatment. c. After 7 days Jessica must be retested for chlamydia. d. Jessica is also being treated for gonococcal infections since they often accompany chlamydial infections.

A

Answer: C
Rationale: It has been determined therapy with azithromycin or doxycycline is highly effective therefore these patients don’t need retested after treatment unless they are pregnant. It is recommended that Jessica’s partners within the last 60 days should be treated for chlamydia. It is also recommended patients should abstain from sexual intercourse for 7 days after a single dose or until the 7-day regimen is completed. The abstinence should continue until the patient’s sex partner has been treated to prevent reinfection. Chlamydial infections and gonococcal infections often accompany one another so a patient positive for one gets treated for both (UpToDate, 2017).

76
Q

Whitney is 36 weeks pregnant with her first child, and on her screenings, she got a positive result for a chlamydial infection. To prevent the spread to her newborn during
birth she is going to be prescribed an antibiotic by her Women’s Health Nurse
Practitioner. Which one of these treatment options are NOT appropriate for the NP to prescribe Whitney?

a. azithromycin 1g PO once b. doxycycline 100mg PO bid for 7 days c. amoxicillin 500mg PO tid for 7 days d. erythromycin base 250mg PO qid for 14 days

A

Answer: B
Rationale: Doxycycline is contraindicated in pregnancy in the second and third trimester so this medication should not be prescribed for Whitney. Erythromycin estolate is contraindicated during pregnancy because of drug related hepatotoxicity, however erythromycin base is an acceptable regimen to give. Azithromycin and amoxicillin are the recommended regimens for pregnant women being treated for chlamydial infections (UpToDate, 2017).

77
Q

Sara arrives to the clinic today complaining of copious, foamy vaginal discharge. A
culture is obtained and tests positive for the protozoan Trichomonas vaginalis. Sara’s
medication history includes non-compliance with medications that have caused her extensive GI upset. Given this information, what would be the primary treatment regimen for Sara?

a. metronidazole 2 grams PO single dose b. azithromycin 1 gram PO once c. tinidazole 2 gm PO single dose d. metronidazole 500 mg PO bid for 7 days

A
Answer: C Rationale: A and D are both treatment options for Trichomoniasis; however, given Sara’s
medication history of GI upset with certain medications and subsequent non-compliance, tinidazole is the best choice of treatment for her as it causes fewer gastrointestinal side effects than metronidazole (UpToDate, 2017). Answer B is incorrect because the 5-nitroimidazole drugs (metronidazole or tinidazole) are the only class of drugs that provide curative therapy of trichomoniasis, thus azithromycin (an antibiotic), would not be indicated (UpToDate, 2017).
78
Q

According to the CDC, what medication is the first-line medication used to treat syphilis?

a. penicillin G IM b. doxycycline PO c. azithromycin PO d. zosyn IV

A

Answer: A
Rationale: Per the CDC 2015 guidelines for the management of syphilis, parental administration of penicillin G (by IM route) is the recommended treatment for syphilis. Doxycycline can be used if the patient has a penicillin allergy but is not recommended in the absence of an allergy or other contraindication. Azithromycin should only be used if both penicillin and doxycycline cannot be used and should be used with caution and not as a first-line medication. Zosyn is not a recommended therapy for syphilis.

79
Q

If a pregnant woman presents with syphilis, and is allergic to penicillin, what is the recommended treatment according to the CDC?

a. Doxycycline 100 mg PO twice daily b. Erythromycin 250 mg PO four times daily c. Tetracycline 500 mg POI four times daily d. Desensitize and treat with benzathine penicillin

A

Answer: D
Rationale: While doxycycline and tetracycline are both acceptable alternative treatments for syphilis in case of a penicillin allergy, they are both contraindicated in pregnancy as they are category D medications. Erythromycin is also a category D medication and is not utilized in the treatment of syphilis. The only safe medication to treat syphilis in the pregnant patient is penicillin, and desensitization and careful monitoring of the patient is necessary to treat syphilis in the pregnant patient with a PCN allergy.

80
Q

Absolute contraindications in hormone therapy include all of the following EXCEPT:

a. Uncontrolled hypertension b. Known or suspected pregnancy c. Diabetes Mellitus d. Acute liver disease

A

Answer: C (Diabetes Mellitus) Rationale: Uncontrolled Hypertension, known or suspected pregnancy, and acute liver disease
are all absolute contraindications to hormone therapy (Found in textbook Box 56.1 on page 976). Diabetes Mellitus is not contraindicated in hormone therapy.

81
Q

Women with low estrogen levels, after menopause, are more likely to report any of the following symptoms EXCEPT:

A. Mood changes B. Vaginal dryness C. Insomnia D. Cold intolerance

A

Answer: D (Cold intolerance) Rationale: Vaginal dryness, insomnia, and mood changes are all very common symptoms for women who are perimenopausal or postmenopausal. Cold intolerance is not a common symptom, as many women experience hot flashes. Any of these symptoms may indicate a need for hormone replacement therapy for symptom control, but not for prolonged use. (Found in textbook on page 972.)

82
Q

Which of the following statements about the use of Hormone therapy is TRUE?

A. Alcohol decreases the circulating levels of estrogen
B. Patients on phenytoin metabolize estrogen at a slower rate C. Use of hormone therapy containing estrogen plus a progestogen is linked to an increased risk of colon cancer D. An increased dose of estrogen may be needed in smokers

A

Answer: D
Rationale:
D is correct because an increased dose of estrogen may be needed in smokers because only half of the serum level achieved in nonsmokers is reached (Textbook pg. 976, Interactions paragraph)
A is incorrect because alcohol increases the circulating levels of estrogen due to the
liver’s preoccupation with metabolizing the alcohol at the expense of estrogen (Textbook
pg. 976, Interactions paragraph)
B is incorrect because patients taking phenytoin metabolize estrogen at a faster rate (Textbook pg. 976, Interactions paragraph)
C is incorrect because the use of hormone therapy containing estrogen plus a progestogen in linked to a lowered risk of colon cancer (Textbook pg. 977)

83
Q

When providing patient education for individuals starting hormone therapy, which of the following information SHOULD NOT be included:

A. It may take up to 4 weeks for the patient to experience a decrease in
symptoms B. Management of menopause is achieved on the highest dose possible for as long as the patient wants C. Patients should be encouraged to talk to their provider about any adverse events D. In the event of a missed dose the patient should not double the next dose

A

Answer: B (Management of menopause is achieved on the highest dose possible for as long as the patient wants)
Rationale: Patients should be advised that management is achieved on the lowest dose and for the shortest duration possible due to increased risk of breast cancer, CHD, and VTE associated with long term use. Patients are encouraged to reach out to their provider when they feel discontinuation is appropriate (Found in textbook pgs 975 & 981).

84
Q

Clara is a 42 year old female patient who has come to you for her yearly physical exam. She expresses that she is finished having children and is curious about her options for birth control. When choosing birth control option that would work for her, absolute contraindications for combination oral contraceptive pills would include all of the following EXCEPT:

E. Family history of breast cancer F. Liver disease G. Current pregnancy H. Personal history of embolic event

A

Answer: A (Family history of breast cancer)
Rationale: Absolute contraindications for combination oral contraceptive pills include thombophlebitis, thromoembolic disorder, cerebral vascular disease, coronary occlusion, impaired liver function, breast cancer, abnormal vaginal bleeding in the absence of a diagnosed cause, pregnancy, and smokers older than 35 years old. (Found in textbook pg. 967 box 55.2 ).

85
Q

When deciding which contraceptive agent is most appropriate the practitioner should consider all of the following measurements EXCEPT:

E. Height F. Blood pressure G. Lipid panel H. Body mass

A

Answer: A (height)
Rationale: When selecting the most appropriate contraceptive agent for a patient the practitioner should consider body mass index because the obese patient may require higher doses of estrogen and progesterone. Additionally, baseline blood pressure, lipid panel measurements and liver and renal function panels should be taken into consideration to determine if the patient is an appropriate candidate for oral contraception. Height is not a determining factor of the appropriate agent. (Found on textbook page 966).

86
Q

Susan is a patient who was prescribed a non-opioid medication to relieve her pain. However, she has come in to see you with complaints of increasing pain now categorized as moderate, despite the prescribed medication regimen. What is NOT a possibility of the next step for you as the APRN to control her pain:

a. Move to a low-dose opioid/non-opioid combination drug instead b. Increase the dose of the medicine previously prescribed c. Increase the frequency of the medicine previously prescribed d. Using OLDCARTS, complete an assessment of the specific characteristics of
her pain

A

The answer is C, because you would never increase the frequency of an opioid drug that is already prescribed to work for a set duration of time. The drug will build up in the system due to the half-life overlap if it is scheduled too frequently. a. Is not correct, because this is an acceptable next step in prescribing opioids when the pain increases to the moderate category. b. is not correct, because increasing the dose of a drug would be an acceptable next step in prescribing opioids. d. is not correct, because this step is always necessary before changing a drug prescription. Assessing the pain using the OLDCARTS acronym will help you as the provider to know what your next step should be.

87
Q

Which of the following is a weak opioid agonist?

a. Morphine b. Loperamide (Imodium) c. Hydromorphone (Dilaudid) d. Nalmafene (Revex)

A

The correct answer is B, Loperaminde (Imodium). According to slide 7 of the “Therapeutic Use of Opioids” powerpoint, both morphine and hydromophone (Dilaudid) are strong opiod
agonists. Slide 16 of the same powerpoint states that loperamide (Imodium) is a weak opioid agonist, and slide 18 states that Nalmafene (Revex) is an opioid antagonist used to reverse the effects of opioids.

88
Q

Tracy is a patient on your unit recovering from a total hip replacement procedure this afternoon, which was the first surgical procedure she has ever had. In bedside report, the day shift nurse tells you he gave Tracy her first dose of PRN 80mg oxycodone (Oxycontin) at 1830. You are performing Tracy’s 1900 assessment and notice her respirations are 8/minute, her
pupils appear constricted and she is acting very drowsy. What will you do next?

a. Press the Code Blue button and call for assistance b. Check the MAR for an order for naloxone (Narcan) and administer c. Check the MAR for an order for Diphenoxylate (lomotil) and administer d. Check Tracy’s blood glucose

A

Correct answer is B, because it appears Tracy is having an overdose reaction from the large dose of oxycodone. Since this is Tracy’s first surgical procedure, it is assumed she is naive when it comes to opioid pain medications, and 80mg was a large starting dose for such an individual. According to slide 18 of the opioid powerpoint, naloxone (Narcan) is an opioid antagonist, so you would want to administer this drug ASAP to reverse the effects of the oxycodone. You would not administer diphenoxylate (lomotil) because this medication is for GI upset and would not be helpful in this situation.

89
Q

You see a patient with chronic pain for which you have decided an opioid should be prescribed. Which of the following are true (select all that apply):

A. Always start at a low dose and go slow if increasing opioid dosing B. Initiate the patient on a long-acting opioid C. Initiate the patient on a short-acting opioid D. Initiate the patient on both a short and long-acting opioid

A

Answer: A & C According to the CDC Guidelines for Prescribing Opioids for Chronic Pain, it is most appropriate
to start patients on the lowest effective dose of a short-acting opioid to control pain and the prescriber should always start low and go slow if prescribing an opioid for pain control. It would not be appropriate to start the patient on both a short and long-acting opioid or to only initiate them on a long-acting opioid.

90
Q

Which patient is a good candidate for a fentanyl patch?

a. John, 26, has just had an abdominal surgery and needs pain relief for his incision. He has never taken an opioid for pain.
b. Sally, 64, is in the ICU having chronic cancer pain, has a fever of 104 degrees F,
and is diaphoretic.
c. Graham, 39, fractured his femur and rates his pain 10/10. d. Jean, 62, is a cancer patient who has been taking 60mg oral morphine daily for the
last 8 days. She is still having chronic cancer pain.

A

Correct Answer: D) Fentanyl transdermal patch should be used in opioid-tolerant patients with a chronic pain process. The patient should have required oral morphine 60 mg or another equivalent opioid every day for the last 7 days to be considered tolerant.

Incorrect answers:
A) Fentanyl transdermal patch should not be used for acute pain or in someone who has not consistently taken opioids.
B) Heat may increase the absorption of a transdermal fentanyl patch, which may result in increased delivery of the medication/potentially lethal overdose. The patch should not be applied to skin that is wet.
C) Fentanyl patch should not be used for acute pain and also has a delayed onset of 12-16 hours after placement. Graham needs faster pain relief than the patch can provide.
Resources: Chapter 7 of Pharmacotherapeutics for Advanced Practice, page 105. Therapeutic Use of Opioids Drug Characteristics lecture, slide 12.

91
Q

Havara is a 47 year-old-female with chronic pain. She takes opioid medication daily to help with pain symptom relief; she states that the medication helps very much. However, recently, she complains that she only has a bowel movement every 5-6 days. What treatment recommendation would you provide to Havara?

a. Reduce the dosage of opioid medication b. Reduce the frequency of opioid medication c. Supplement the opioid medication with senna, bowel stimulants, and laxatives as
needed
d. Switch the pain medication from an opioid to a non-opioid analgesic

A

Correct Answer: C) Havara should supplement her opioid medication with senna, bowel stimulants, and laxatives as needed. Because her pain is being well-controlled by the medication dosage, frequency and drug being taken, an adjunctive therapy to combat the side effect of constipation should be added.
Resource: Opioid Class Characteristics powerpoint slide 18
Incorrect Answers: A. Havara has had adequate pain relief from her medication so the dosage should not be
adjusted unless the pain management is being affected. B. Havara has had adequate pain relief from her medication so the frequency should not be adjusted unless the pain management is being affected. C. Havara has had adequate pain relief from her medication so switching to a non-opioid medication should not be considered unless pain management is being affected.

92
Q

What is the primary goal of pharmacological opioid pain management?

a. To eliminate a patient’s pain. b. To treat a patient’s pain and wean them off of opioid use. c. To manage a patient’s pain at a level acceptable to the patient with minimal side
effects d. To reduce a patient’s pain while also using non-opioid medications

A

Answer: C - rationale: realizing that pain is a common symptom and cannot always be eliminated completely, a realistic goal of opioid therapy is to have the pain be manageable by the patient with the least amount of side effects possible, since opioids
can cause significant side effects reference: slide 8 & 9 of “Pain Management Into” lecture, audio content

Wrong answer rationale:

a) it is not practical & sometimes not even possible to completely eliminate a patient’s
pain. b) weaning off opioid use is not a primary goal of pain management
d) the goal of opioid therapy isn’t always to reduce pain - but to make it manageable for the patient & using non-opioid meds is not a goal of opioid therapy

93
Q

Why is morphine used to treat acute pulmonary edema? Select all that apply.

a. It helps decrease pain from peripheral fluid buildup b. It helps decrease anxiety caused by shortness of breath
c. It reduces cardiac preload and afterload d. It increases cardiac preload and decreases afterload

A

Answer: B & C - rationale: morphine decreases anxiety associated with shortness of breath caused by acute pulmonary edema, thus reducing cardiac preload & afterload reference: slide 14 of “Opioid Therapy” lecture, audio content

Wrong answer rationale:
a. Pain/pressure from peripheral edema would more likely be relieved by a
diuretic & not morphine d. morphine reduces preload, not increases it

94
Q

Your patient, Mark, expresses concern about his husband, Joe, who has
been battling an opioid addiction. Mark is concerned about Joe dying of an overdose. You prescribe naloxone and give Mark information to use on Joe if there is an overdose. Which of the following statements is
INCORRECT?

a. You will only need to administer naloxone once, as its duration of action
outlasts
many opioids. b. Naloxone can be given by injection or nasally.
c. Side effects of Naloxone are rare, but include: tachycardia, ventricular fibrillation, and
cardiac arrest.
d. It is used to reverse opioid side effects, such as respiratory depression.

A

Correct Answer: A - rationale: Opioids typically outlast naloxone as Naloxone’s duration
of action is approximately 45 minutes, shorter than opioids. (Textbook: pg. 106)

Wrong answer rationale:(b) Naloxone in activated when given orally. (Textbook: pg. 106) (c) Side effects of naloxone are rare, but occur due to release of neurotransmitters when
the antagonist is administered. (Textbook, pg. 106)
(d) Side effects of opioids are sedation, confusion, respiratory depression, itching, nausea/vomiting, constipation. Opioid antagonists work to by reversing
respiratory depression. (Textbook, pg. 106, & lecture on opioid drug
characteristics)

95
Q

For which of the following patients would the use of an opioid analgesic be
contraindicated?

a. 53 year old man with metastatic cancer b. 21 year old male with severe asthma c. 37 year old female with fibromyalgia d. 42 year old female in postoperative recovery

A

Correct Answer: B - rationale: opioids are contraindicated in conditions associated with decreased respiratory reserve because of their risk of respiratory depression (Lecture:
Opioid Therapy Class Characteristics)

Wrong answer rationale:(a) Opioids are appropriate treatment for cancer-related pain (Ch. 7 of textbook)
(c) Tramadol, a weak opioid, is effective in treating fibromyalgia (Lecture: Therapeutic
Use of Opioids Drug Characteristics)
(d) Postoperative pain is often treated with opioid medications because the pain can be
severe (Ch. 7 of textbook)

96
Q

Transdermal fentanyl patches are indicated for which patient?

a. anyone with painb. chronic pain who cannot take oral medsc. only cancer patientsd. nobody

A

Answer: B
Rationale– Indicated for chronic pain who cannot take oral meds. The patch is designed
to provide analgesia for 72 hours, altho some may experience breakthrough after 48 .Unique formulation. Each patch carries a relatively large amount of medication, and starting a patient on a fentanyl patch could result in over medication, sedation and respiratory depression. As such, the fentanyl patch should only be used for opioid
tolerant patients.
* per Therapeutic Use of Opioids PP

97
Q

Opioid tolerance usually develops with prolonged use for most adverse side effects except for which common side effect (which requires prophylactic intervention)?

a. respiratory depression b. Nausea/vomiting c. Constipation d. Sedation

A

Answer: C - rationale: tolerance usually develops within a few days to most of the adverse reactions associated with opioids except for constipation. Constipation prevention is needed in patients receiving opioids. (per pg 106 of our text book) Wrong answer rationale: (safety of opioids, pg 106/chapter 7 principles of pharmacology
in pain management)

a. although considered the most dangerous side effect, chronic pain patients on opioids usually develop tolerance to respiratory depression (exceptions are elderly, head injury, closed head trauma, hemodynamic issues, obstructive sleep apnea, and patients with liver/kidney failure) b. Nausea and vomiting usually subside after a few days for most patients using opioids
c. Patients who use opioids for chronic pain will experience less sedation over time and increase their tolerance for this side effect

98
Q

A 32 y/o female asks how she has developed an infection in her urinary tract. As the provider, you explain that the development of UTIs depend upon three different pathophysiological aspects. All of the following answers should be included in your patient education, EXCEPT:v

a. Inoculum size
b. Leukocytes in urine c. Adequacy of host’s defense d. Virulence of organism

A

Answer: B - According to the text (page 520), there are three pathophysiological aspects in the development of a UTI that are to be considered - A, C, and D are all included. B is not. Leukocytes in the urine do not automatically indicate a UTI. Rather it could be a sign of an infection or something more serious.

99
Q

Which of the following symptoms apply when it comes to the clinical diagnostic criteria for symptomatic UTI?

a. Fever b. Worsened urinary urgency or frequency c. Acute dysuria d. All of the above

A

Answer: D - According to the text (page 519), patients presenting with any two of the following symptoms meet the clinical diagnostic criteria for symptomatic UTI.

100
Q

A 20-year-old female presents with an uncomplicated UTI. At what point would her UTI be considered complicated? If symptoms persisted for more than:

a. 5 days b. 7 days c. 10 days d. 14 days

A

Answer: B - According to the text (page 520), a UTI is considered complicated if symptoms have persisted for more than 7 days. Answer A is too soon to be considered complicated. Answers C and D are both several days past the 7 day mark, which is a
significant diagnostic criteria for complicated UTI’s.

101
Q

In the case of UTIs, foods that irritate the bladder include all of the following EXCEPT:

a. Tea b. Chocolate c. Cranberry juice d. All of the above foods irritate the bladder

A

Answer: C - According to the text (page 526), cranberry juice can be used as an
alternative to antibiotics or for the prevention of UTIs. Answers A and B are foods that do irritate the bladder and should be avoided. Answer D is incorrect, because C does not irritate the bladder.

102
Q

All of the following meet the criteria for a diagnosis of a complicated UTI, EXCEPT:

a. UTI in a male b. UTI in a pregnant woman c. UTI in a patient with an indwelling catheter d. UTI in a non-pregnant female with no recent history of UTI

A

Answer: D- According to the text (page 520), answers A, B and C all meet the criteria for diagnosis of complicated UTI. Answer D meets the criteria for diagnosis of an
uncomplicated UTI.

103
Q

Which of the following s/s are indicative of pyelonephritis? (Select all that apply.)

a. Dysuria b. Flank pain c. Nausea and/or vomiting d. Temperature > 38°C (100.4°F)

A

Answer: B, C and D - According to the text (Figure 32.1), flank pain, nausea, vomiting, CVA tenderness, and temperature > 38°C (100.4°F) are s/s of pyelonephritis; dysuria, urinary urgency, and urinary frequency are s/s of both cystitis and pyelonephritis.

104
Q

The best medication treatment for chemotherapy induced nausea and vomiting (CINV) with a high emetic potential include all of the following except:

a. Zofran 4 mg PO b. Giving antiemetic medication prophylactically before and during chemotherapy c. IV antiemetic medication d. Dexamethasone 4-12 mg (IV or PO)

A

A. Recommendations are based on the level of emetic potential, day of treatment, and in some circumstances the drugs as well. NK1R antagonist, a 5-HT3 receptor antagonist, dexamethasone and olanzapine are recommended for high emetic potential chemotherapies. Dosing for dexamethasone is 4-12 mg IV or PO, however IV medications are always preferred. Additionally, medication given before and during the chemotherapy to prevent nausea and
emesis have been proven the most effective.

105
Q

The most successful protocol for eradication of H. pylori/treatment of peptic ulcer disease:

A) bismuth monotherapy B) therapy using bismuth compounds, metronidazole (Flagyl), and amoxicillin (Amoxil Polymox) in
combination -triple therapy C) bismuth compounds and amoxicillin (Amoxil Polymox) D) all of the above equally effective

A

Answer : B
Triple therapy that includes two antibiotics and bismuth subsalicylate is the most effective regimen. It eliminates the bacteria and prevents recurrence of ulcers in 90% of people who receive this treatment. Bismuth monotherapy is successful in eradicating H. pylori at 0-32% successful rate.

106
Q

All of the following are true about antiemetic (N/V) medications except:

A) They act on the vomiting center in the brain
B) They work via various mechanisms including D2 receptor antagonist and H1 receptor
antagonists C) They work best once N/V is already occurring vs. prophylactically D) They have multiple effects including anticholinergic, antidopaminergic and antihistaminic

A

Answer: C. The medications are most effective in prophylaxis than treatment
Rational: N/V medications are most effective in prophylaxis than treatment. The other answers are all correct, N/V medications do act on the vomiting center of the brain, their mechanisms of action include D2 receptor antagonist and H1 receptor antagonists, and their effects include anticholinergic, antidopaminergic and antihistaminic.

107
Q

Which of the following combinations would you prescribe as a first line therapy for an individual with an exacerbation of IBS-D with associated abdominal bloating/gas, after
non-pharmacological methods for control have been unsuccessful?

a) Magnesium citrate (osmotic laxative) AND Bentyl (antispasmodic) b) Loperamide (antidiarrheal) ONLY c) Loperamide (antidiarrheal) AND Bentyl (antispasmodic) d) Bentyl (antispasmodic) AND Lomotil (antidiarrheal)

A

Correct answer = C
Rationale: “First-line therapy is selected based on the presenting symptoms… Antidiarrheal agents are recommended in patients with IBS-D. Loperamide is the preferred agent because it causes the least CNS activity and has the added benefit of improving anal sphincter tone. With the additional problems of pain, gas and abdominal bloating, a trial of antispasmodic may relieve symptoms. Dicyclomine is the agent of first choice because of its shorter half-life, which may minimize anticholinergic side effects of the class.”
A is incorrect as magnesium citrate is an osmotic laxative, an agent used to treat constipation. B is incorrect as the patient also has symptoms of abdominal bloating/gas. See rationale above. D is incorrect as Lomotil is not a first line antidiarrheal choice due to its increased anticholinergic side
effects. “Unresolved complaints of IBS-D can be treated with lomotil, which has a longer duration of action but can be addictive because of its opioid properties and should be reserved for short-term use.”

108
Q

A patient of yours recently had gastric bypass surgery. Prior to the surgery they were taking the medication metoclopramide (Reglan) for their nausea and vomiting. As a result of the gastric bypass surgery the patient is experiencing Dumping Syndrome (extremely and abnormally rapid gastric emptying) which can also cause nausea and vomiting. What
is your plan of action concerning their metoclopramide therapy?

A. Continue the metoclopramide therapy. B. Discontinue metoclopramide therapy until further notice. C. Double the dose of metoclopramide given in a day. D. Continue metoclopramide therapy and add also add an antiemetic drug.

A

Answer: B: discontinue metoclopramide therapy until further notice. Rationale: Metoclopramide is a prokinetic drug that treats nausea and vomiting by increasing the gastric emptying and peristalsis. Metoclopramide would further increase the already rapid gastric emptying that occurs with dumping syndrome thus making the nausea and vomiting worse. It would be best to
discontinue the metoclopramide until the dumping syndrome is resolved.

109
Q

For patients suffering from GERD, which lifestyle modifications are recommended:

a. Where tight fitting clothing b. Wait 3 hours after eating to lay down c. Dietary changes are not necessary d. Elevate head of bed by 6-8 inches.

A

Correct Answer: D
Rationale: Lifestyle and dietary modification — Although several lifestyle and dietary
modifications have been used in clinical practice, a systematic review of 16 randomized trials that evaluated the impact of these measures on GERD concluded that only weight loss and elevation of the head end of the bed improved esophageal pH-metry and/or GERD symptoms.
We suggest the following lifestyle and dietary measures:
●Weight loss for patients with GERD who are overweight or have had recent weight gain.
●Elevation of the head of the bed in individuals with nocturnal or laryngeal symptoms (eg, cough, hoarseness, throat clearing). This can be achieved either by putting six- to eight-inch blocks under the legs at the head of the bed or a Styrofoam wedge under the mattress. We also suggest a corollary to this recommendation: refraining from assuming a supine position after meals and avoidance of meals two to three hours before bedtime.
●Dietary modification should not be routinely recommended in all patients with GERD. However, we suggest selective elimination of dietary triggers (fatty foods, caffeine, chocolate, spicy foods, food with high fat content, carbonated beverages, and peppermint) in patients who note correlation with GERD symptoms and an improvement in symptoms with elimination.
Other measures that have a physiologic basis but have not consistently been demonstrated to improve reflux symptoms include:
●Avoidance of tight-fitting garments to prevent increasing intragastric pressure and the gastroesophageal pressure gradient.
●Promotion of salivation through oral lozenges/chewing gum to neutralize refluxed acid and increase the rate of esophageal acid clearance.
●Avoidance of tobacco and alcohol as both reduce lower esophageal sphincter pressure and smoking also diminishes salivation.
●Abdominal breathing exercise to strengthen the antireflux barrier of the lower esophageal sphincter.

110
Q

Which of the following drugs would be the first-line choice for this patient?

a) Metronidazole (Flagyl)
b) Trimethoprim/sulfamethoxazole (Bactrim)
c) Piperacillin-Tazobactam (Zosyn) d) None of the above

A

Rationale: Metronidazole (Flagyl) is not used in the treatment of cystitis. TMP/SMX (Bactrim) is considered first-line treatment for uncomplicated cystitis in adults.(Nitrofurontin (Macrobid) is also a first-line treatment option, but it was not listed.) Piperacillin-Tazobactam (Zosyn) is administered parenterally in the treatment of complicated cystitis.

111
Q

Further conversation with your patient reveals that she recently stopped taking her birth control pills, and that she and her partner are “open” to conceiving. You have the patient take a urine pregnancy test, which is negative. You consider the possibility that the patient may already be carrying a desired pregnancy that is too early to detect, or that she may conceive during treatment. Which of the following antibiotics would be the best choice in this scenario?

a) Metronidazole (Flagyl) b) Trimethoprim/sulfamethoxazole (Bactrim)
c) Amoxicillin-clavulanate (Augmentin)
d) Ciprofloxacin (Cipro)

A

Rationale: Metronidazole (Flagyl) is not used in the treatment of cystitis. TMP/SMX (Bactrim) is not the best choice in a patient who may be or may become pregnant, as this drug works by inhibiting folic acid synthesis and therefore may increase the risk of fetal neural tube defects.
Amoxicillin-clavulanate (Augmentin) is an empiric option for the treatment of UTIs and is generally
considered safe in pregnancy (Category B). Ciprofloxacin is used in the treatment of UTIs, but Augmentin is a better choice, as fluoroquinolones are generally avoided during pregnancy.

112
Q

A 65-year old female presents to you with a fever of 101.4 F and suprapubic pain. She recently had an
indwelling Foley catheter placed due to progressive worsening of her multiple sclerosis. All of the following are true regarding your approach to her care and treatment, EXCEPT:

a) You thoroughly re-evaluate the patient’s need for the indwelling Foley catheter, assessing the risks vs. benefits, and decide it is necessary to maintain the catheter for the patient’s quality of life b) You order a urinalysis (with reflex to culture) to be obtained, preferably after changing her catheter c) Because the urine culture demonstrates 10^5/mL organisms, you decide to prescribe a broad-spectrum antibiotic d) You choose to prescribe Ciprofloxacin (a Fluoroquinolone), 250mg for 3 days*

A

D. Rationale: A fluoroquinolone is an appropriate antibiotic to prescribe in this situation. However, because this is a case of complicated cystitis (the patient is a 65-year old female with the comorbidity of MS and has an indwelling Foley catheter), in which the patient is both symptomatic and has a positive culture, you would want to prescribe this antibiotic at this strength for 7-14 days. The other answers are all appropriate in your approach to her care. First, you always want to be re-assessing the patient’s need for an indwelling Foley catheter. Second, it is necessary to obtain a urinalysis because the patient presents with urinary symptom. Finally, as already discussed, prescribing an antibiotic is the correct action to take.

113
Q

A 68 Y/O male presents to his PCP complaining of urinary frequency, hesitancy, and nocturia. Additionally, he is experiencing 7/10 pain in his lower abdomen and perineum area. His temperature is 100.1F. After taking a history, you are debating between a diagnosis of complicated cystitis or prostatitis. What diagnostic tests would you run to differentiate?

a) Urinalysis b) Blood PSA level c) Prostate exam d) All of the above

A

D. Rationale: Because the patient is complaining of pain in the lower abdomen and perineum area, it is important to determine whether the cause of symptoms is an infection of the prostate or infection of the bladder to determine appropriate treatment. To confirm the diagnosis of prostatitis, a prostate exam, blood PSA level, and urinalysis must be completed. Pain and tenderness will be elicited during the prostate exam, the PSA level will be increased, and the urinalysis will be positive for bacteria.

114
Q

28 year-old female presents to her PCP with a 4 day history of dysuria, fever, nausea/vomiting and headache. The PCP orders a UA with reflex to culture, CBC and chem7. Upon exam the patient is noted to have flank pain and currently has a fever of 101.8 oral. Although the labs are still pending, the PCP is
highly suspicious of pyelonephritis. Which of the patient’s presenting signs/symptoms could limit the PCP in treating the patient in the outpatient setting and require hospitalization?

a) Dysuria b) Fever c) Nausea and vomitingd) Headache

A

C. Rationale: Severe nausea/vomiting is common in pyelonephritis, and may be so severe that the patient is not able to tolerate PO antibiotics. In this case, hospitalization would be required for IV antibiotics and IV fluids for hydration. Dysuria, fever, and headache are also common in pyelonephritis but do not potentiate hospitalization.

115
Q

A 65-year-old woman presents to you with a complaint of back pain, dysuria, urinary urgency and frequency. The patient has a PMH of coronary artery disease (CAD), Diabetes Mellitus (DM), and osteoarthritis (OA). She has a surgical history of a left total knee arthroplasty, which occurred in 2010. and a hysterectomy from 30 years ago. She also endorses having some difficulty getting around. Which risk factors are specifically related to the development of recurrent cystitis?

a) CAD, DM, and OA b) OA, impaired mobility, and her age
c) DM, impaired mobility, and her hysterectomy
d) her age and a history of knee surgery

A

C. Rationale: Risk factors for recurrent cystitis include DM, functional disability, recent sexual intercourse, a prior hx of urogynecologic surgery, urinary retention, and urinary incontinence.

116
Q
Which drug class is considered first line therapy for acute anxiety related to a time-limited
stressor? 

a. SSRIs b. Benzodiazepines c. SNRIs d. TCAs

A
Which drug class is considered first line therapy for acute anxiety related to a time-
limited stressor? a. SSRIs [INCORRECT; considered the drug of choice for GAD; 2-4 week onset of
action, not for acute anxiety attacks] b. Benzodiazepines [CORRECT; Benzos should be used for short-term management of acute phases of anxiety, as well as any subsequent exacerbations] c. SNRIs [INCORRECT; considered the drug of choice for GAD and those with comorbid depression] d. TCAs [INCORRECT; effective in treating GAD and controlling panic attacks in patients with PD and GAD]
117
Q

All of the following contribute to increased severity of benzodiazepine withdrawal syndrome except for:

a. Abrupt discontinuation of drug b. Short half-life of drug c. Long half-life of drug d. Increased duration of use

A

All of the following contribute to increased severity of benzodiazepine withdrawal
syndrome except for: a. Abrupt discontinuation of drug [INCORRECT; A is a true statement. Abrupt discontinuation is associated with withdrawal symptoms of greater severity. Tapering should be gradual, over at least 4 weeks with 10 percent decrease every
3 to 4 days] b. Short half life of drug [INCORRECT; B is a true statement. Drugs with shorter half lives are more associated with withdrawal phenomena, as longer half life drugs are removed at a slower and more steady state] c. Long half life of drug [CORRECT; C is not true] d. Increased duration of use [INCORRECT; D is a true statement. Withdrawal is relatively infrequent with short term use. The longer the duration and the higher the dosage use, the greater the severity of withdrawal]

118
Q

Which of the following is a reason to prescribe a benzodiazepine?

a. They have the least likelihood to cause dependence and are normally used long term. b. Some have a quick response and can be used with psychotherapy or cognitive behavior therapy. c. They should be used as a first-choice drug with a patient experiencing withdrawal from substance abuse. d. The side effects are limited to increased heart rate and respiratory rate.

A

Which of the following is a reason to prescribe a benzodiazepine?
a. They have the least likelihood to cause dependence and are normally used long term. [INCORRECT; Long-term benzodiazepine medication should be avoided. All benzodiazepines are associated with a risk of dependence. Benzodiazepines have a sedative effect, they predispose the patient to accidents, cause disturbances of the cognitive function and may lead to confusion and agitation] b. Some have a quick response and can be used with psychotherapy or cognitive behavior therapy. [CORRECT; Benzos such as clonazepam (Klonopin), lorazepam (Ativan), diazepam (Valium) and alprazolam (Xanax) are useful for panic attacks. They are safe when used as directed and often bring quick relief from panic symptoms. Cognitive psychotherapy is useful in many cases of anxiety] c. They should be used as a first-choice drug with a patient experiencing withdrawal from substance abuse. [INCORRECT; Benzodiazepines should be avoided with withdrawal. Anxiety, sleep disorders and adverse effects of the abused drugs have made many drug addicts additionally dependent on benzodiazepines. If deemed necessary, the risk of developing dependence may be reduced if the stopping time is already planned at the time of prescription. Not suitable in alcohol abuse. Should not be used as first choice drugs] d. The side effects are limited to increase heart rate and breathing. [INCORRECT; The most common adverse effects of benzodiazepines are sedation, worsening of psychomotor functions and transient memory disorders. In addition, typically a low heart rate and breathing can occur]

119
Q

If a patient shows no response to a first line anxiolytic (SSRI) defined as: shows no sign of improvement after 4-6 weeks at the maximally tolerated dose then the SSRI should be tapered off, and a different medication, typically another SSRI, should be attempted using what dose and titration principles? (ex. Sertraline with max dose being 150mg/day)

a. Start initial loading dose at 100mg/day for the first week. b. Start at 5mg/day for the first two weeks then titrate up by 2.5mg/day in the following weeks until symptoms are relieved or maximum dose is achieved. c. Initiate Sertraline at 25mg/day, after a week increase to a therapeutic dose of 50mg/day and continue for four to six weeks. If patient does not experience a robust clinical outcome, Sertraline can be titrated up every week/bi-weekly in 50 mg increments to a maximum dose of 150 mg/day. d. Start at the max allowable dose (150mg/day) and decrease if patient experiences moderate to severe adverse effects.

A

A. Start initial loading dose at 100mg/day for the first week. [INCORRECT; Could lead to adverse effects like serotonin syndrome] B. Start at 5mg/day for the first two weeks then titrate up by 2.5mg/day in the following weeks until symptoms are relieved or maximum dose is achieved. [ INCORRECT; Would take way too long for the patient to reach therapeutic levels and runs the risk of the patient becoming noncompliant] C. Initiate Sertraline at 25mg/day, after a week increase to a therapeutic dose of 50mg/day and continue for four to six weeks. If patient does not experience a robust clinical outcome, Sertraline can be titrated up every week/bi-weekly in 50 mg increments to a maximum dose of 150 mg/day. [CORRECT; this is a safe taper for this type of medication and would typically avoid adverse effects like serotonin syndrome depending on the patient’s dosing weight/extraneous metabolic processes] D. Start at the max allowable dose (150mg/day) and decrease if patient experiences moderate to severe adverse effects. [INCORRECT; Could lead to serotonin syndrome]

120
Q

A patient is brought in by her mother to the emergency room after being found with an empty prescription bottle of alprazolam (Xanax). The patient is very sedated, hypotonic, confused and her respirations are depressed. You suspect Benzodiazepine overdose. What should you expect the course of action to be to treat this patient?

a. Administer Naloxone IV and monitor until the patient recovers then admit to the
psychiatric unit. b. Administer a single dose of Flumazenil IV and monitor the patient’s vitals until they are stable, then discharge the patient. c. Administer a single dose of activated charcoal and monitor the patient’s vitals until they are stable and discharge. d. Administer Flumazenil IV and monitor the patient’s vitals. Delay discharge when the patient’s vitals are stable as a repeated dose of Flumazenil may be necessary.

A

a. Administer Naloxone IV and monitor until the patient recovers then admit to the psychiatric unit. [INCORRECT; Naloxone is an opioid antagonist used to treat
opioid overdose not Benzodiazepine overdose] b. Administer a single dose of Flumazenil IV and monitor the patient’s vitals until they are stable patient recovers then discharge the patient. [INCORRECT; while Flumazenil is the correct drug of choice for Benzodiazepine overdose, it has a short half-life and repeated doses may be needed as re-sedation can occur so discharging the patient after first stabilizing is incorrect. c. Administer a single dose of activated charcoal and monitor the patient’s vitals until they are stable and discharge. [INCORRECT; Single-dose activated charcoal is not routinely recommended, as the risks far outweigh the benefit. BZD are very rarely fatal in overdoses, and the altered mental status from BZD overdose greatly increases the risk of aspiration following oral charcoal dosing] d. Administer Flumazenil IV and monitor the patient’s vitals. Delay discharge when the patient’s vitals are stable as a repeated dose of Flumazenil may be necessary. [CORRECT; Flumazenil is the only Benzodiazepine receptor antagonist available for clinical use. But because it has a short half life of 0.7-1.3 hours, re-sedation commonly occurs and repeated doses of flumazenil may be needed]

121
Q

You have just diagnosed your patient with GAD. He does not have any comorbid conditions, has
no allergies, and is not currently taking any medications. Describe the rational prescribing
process for this patient.

a. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a low
dose, and re-evaluate clinical presentation in three weeks. b. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a low dose, and re-evaluate clinical presentation in five weeks. c. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a high dose, and re-evaluate clinical presentation in three weeks. d. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a high dose, and re-evaluate clinical presentation in five weeks.

A

a. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a low dose, and re-evaluate clinical presentation in three weeks. [INCORRECT; The practitioner should allow 4-8 weeks to pass before re-evaluating or titrating
the dose] b. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a low dose, and re-evaluate clinical presentation in five weeks. [CORRECT; A low dose SSRI/SNRI (first line treatment) should be used, and the practitioner should allow 4-8 weeks to pass before re-evaluating or titrating the dose] c. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a high dose, and re-evaluate clinical presentation in three weeks. [INCORRECT; A patient should never be started on a high dose of antidepressants. The practitioner also only allowed three week’s time to pass before re-evaluating or titrating the dose] d. Begin the patient on a single antidepressant drug, preferably an SSRI or SNRI, at a high dose, and re-evaluate clinical presentation in five weeks. [INCORRECT; A patient should never be started on a high dose of antidepressants]

122
Q

Benzodiazepines exert a therapeutic effect by binding to ______ receptors in the brain.

a. SABA-A b. LABA c. GABA-A d. OSU-N

A

Correct answer: C - Benzodiazepines cause GABA-A receptors to increase the opening of chloride channels along the cell membrane, leading to an inhibitory effect on cell firing (Pharmacotherapeutics for Advanced Practice- A Practical Approach- Chapter 41 page 707) A-resembles a short-acting beta agonist, which are not associated with Benzodiazepines. B- is a long acting beta agonist with is not related to benzodiazepines. D- Is a made-up answer.

123
Q

n emergency treatment of benzodiazepine overdose, an APRN use/prescribe Flumazenil
(Mazicon) which is considered a _______.

a. SNRI b. Beta Blocker agonist c. Benzodiazepine receptor antagonist d. Opioid receptor agonist

A

Correct answer: C - Benzodiazepine receptor antagonists block the action of benzodiazepines and reverses sedative effects. (Pharmacotherapeutics for Advanced Practice- A Practical Approach- Chapter 41 page 709). A- a SNRI would not reverse the effects of Benzos. B- a beta blocker would not reverse the effects of Benzos. D- an opioid agonist would not reverse the effects of a benzo, and perhaps make it worse

124
Q

What symptoms does a patient experience when withdrawing from a benzodiazepine?

a. Anxiety, irritability, nausea, confusion, and depression b. Vomiting, high temperature, and restlessness c. Hopelessness, sadness, guilt, loss of interest d. None of the above

A

Correct answer: A- All these are symptoms per our textbook box 41.5 (Pharmacotherapeutics for Advanced practice 2015, p. 717). B- High temperatures and vomiting not associated with withdraw. C- symptoms of depression. D- A is the right answer

125
Q

Which of the following is true of anxiety disorders?

a. They often occur with many other psychiatric disorders b. They often occur independent of other comorbidities c. Features of anxiety disorders include autonomic hypoactivity d. Treatment includes Buspirone as a first line drug

A

Correct answer: A - Anxiety disorders often occur with many other psychiatric disorders B - Inaccurate as anxiety disorders tend to occur with other disorders. C - Features of anxiety disorders include autonomic hyperactivity, not hypo D - First line treatment of anxiety disorders are SSRIs or TCAs; Buspirone is a second line treatment (References: Anxiety-A case presentation lecture, slide 7 and 25).

126
Q

When should the nurse practitioner plan to follow up with a patient who has just started
taking Escitalopram 10mg daily (SSRI) for anxiety?

a. 7-10 days b. 2-3 weeks c. 2 months d. 3-6 months

A

Correct answer: B - 2-3 weeks. (Anxiety-A case presentation lecture, slide 29.) Our text states that there is a 2-4-week delay until onset of therapeutic effect when starting SSRIs therefore the nurse should follow up within this time period to see how the patient is responding to the current treatment (Pharmacotherapeutics for Advanced practice, page 706). A - incorrect as 7-10 days would not allow enough time for the drug to start taking effect and show symptom improvement. C and D - incorrect as the drug begins to show reduction in anxiety within 2-4 weeks, thus the patient should be reassessed sooner to see if any changes in the current regimen should be made.

127
Q

A patient has recently been diagnosed with generalized anxiety disorder (GAD). Which of the following drug options would you first consider when deciding on what medication
to prescribe?

a. Buspirone b. Benzodiazepines c. SSRI or SNRI d. MAOIs

A

Correct answer: C. SSRI or SNRI Our text states that SSRIs and SNRIs are considered first line therapy for GAD (Pharmacothereapeutics for Advance practice, page 712). A - is incorrect as buspirone is indicated after confirmed failure or intolerance to multiple members of the SSRIs or SNRI classes has occured (Pharmacotherapeutics for Advance Practice, page 712). B - is incorrect as benzodiazepines are not considered first line therapy however they may be added as adjunct treatment when SSRIs or SNRIs have failed. Benzos are sometimes used when first starting SSRI or SNRI treatment to help support patients while they are waiting the weeks it takes for the SSRI/SNRI to start improving symptoms (Pharmacotherapeutics for advance practice, page 712). D - is incorrect as their effectiveness in GAD has not been proven, these drugs are not considered first line because of it’s dietary restrictions and potential for serious drug interactions (Pharmacotherapeutics for Advance Practice, page 711).

128
Q

Jane is a 26 year old female presenting to the clinic with moderate ankle pain from a recent fall. Her medical history includes chronic diverticulitis and a past GI bleed. She is not currently taking any pain medications. What drug would be the most appropriate for the patient?

a. Acetaminophen (Tylenol) b. Aspirin (an NSAID) c. Hydromorphone (an opioid) d. Naproxen (an NSAID)

A

Correct answer is A, acetaminophen, based on her history of GI issues and her level of pain. NSAID’s are inappropriate as they have a higher risk of GI problems and anticoagulation properties. An opioid is not appropriate for her condition and level of pain. Reference: Pharmacotherapeutics for Advanced Practice textbook, pages 100-104. (Alexa)

129
Q

You are assessing a 14 year old who was brought in with lethargy and jaundice. Upon further assessment the mother reports the child was using Aspirin (Salicylate) and was symptomatic with a flu-like illness. What common adverse reaction has likely occurred?

a. Tinnitus (lasting 2-3 days once medication is discontinued) b. Acute Renal Failure (reversible with dialysis) c. Reye’s Syndrome d. Iron Deficiency

A

Correct answer is C (Reye’s Syndrome). As discussed in lecture, Reye’s Syndrome can cause
fatty liver and encephalopathy when using Aspirin in children under the age of 18 who are symptomatic with varicella or flu-like illness. Although the other listed answers are known adverse reactions when using Aspirin, c is the best answer. Referenced from Analgesic Lecture (3/31/17) Slide 10. (Sarah)

130
Q

Michael, age 57, is admitted to the hospital for a coronary artery bypass graft surgery. While taking a medical history, the perioperative nurse notes current medications as the following: Albuterol, PRN for asthma, Lisinopril for hypertension, and Ibuprofen, 1200mg BID for OA. Which of these medications carries the greatest risk for the patient?

A. Albuterol B. Lisinopril C. Ibuprofen D. Multivitamin

A

Correct answer: C Ibuprofen: ALL NSAID medications carry a Black Box Warning, due to the increased risk of CV adverse events and are contraindicated in perioperative pain treatment for patients undergoing coronary artery bypass surgery. While Lisinopril may increase the risk for hypotension during anesthesia, it is not the best answer. Albuterol is an acceptable PRN treatment for asthma, and should be used cautiously with CV disease, but it is not the best answer. (Pharmacotherapies for Advanced Practice, Chapter 36, pg. 598). (Steffanie)

131
Q

Elizabeth, age 63, is starting acetaminophen treatment for OA. All the following are important for patient education EXCEPT:

A. Patient’s need to be cognizant of other medications and OTCs containing acetaminophen. B. Alcohol intake should be minimized or avoided while taking acetaminophen. C. Do not exceed the maximum daily dosage of 1 gram per day D. Patients should take acetaminophen only when they are experiencing pain

A

Correct answer: D Patients with OA should take acetaminophen around the clock, as prescribed,
regardless of pain level to achieve the best outcome for pain management, NOT as needed for pain. Minimization of alcohol consumption, awareness of medications that also contain acetaminophen, and no more than 1 gram of acetaminophen per day are all important elements of patient education. (Pharmacotherapies for Advanced Practice, Chapter 36, pg. 601).(Steffanie)

132
Q

.Before initiating medications, nonpharmacologic therapy for Osteoarthritis includes all of the below except:

A. Moist heat B. Weight loss C. Rest D. Swimming

A

Correct answer: C- Rest. Before initiating drug therapy, the practitioner should recommend appropriate physical active or PT to reduce pain, improve motion, strengthen the surrounding muscles and maintain functional ability. Fitness programs that incorporate swimming, walking, cycling, isometric exercise help promote flexibility. Moist heat helps diminish muscle spasms and relieves stiffness. Additionally, overweight patients should be counseled on the need for weight loss to reduce further joint damage and associated pain. (Pharmacotherapies for Advanced Practice, Chapter 36, pg. 593).(Amanda)

133
Q

A 78 year old female comes into you practice for ankle sprain. She has a history of diabetes mellitus type 2 and hypertension. She explains that the pain is routinely a 4 out of 10 and has not seen any other practitioners for the problem. She states that she has tried to manage the pain rest, massage, heat and ice. You have decided to prescribe a NSAID to help her manage the pain. What must you take into consideration when prescribing an NSAID medications to this patient.

A. Nothing any non-opioid is considered appropriate due to her pain level
B. The patient is elderly and therefore may require a higher dose due to pain sensation being decreased in elderly patients
C. An NSAID with a longer half life and lower dose is appropriate for this patient D. An NSAID with a shorter half-life and a lower dose is appropriate for this patient

A

Correct Answer with Rationale: D: The patient should be prescribed an NSAID with a shorter half-life
and a lower dose because of her age. Additionally, any individual over the age of 65 should be considered high-risk for a GI bleed and should be treated with either a COX-2 inhibitor or a combination of a nonselective NSAID and a gastric protective agent such as a proton pump inhibitor. Although A is correct it is nonspecific and therefore is not the best answer to the question. Elderly patients have decreased metabolism and therefore should not be prescribed higher dose NSAIDS. Finally, NSAIDs with longer half-lifes should also be avoided due to the decreased metabolism associated with the elderly.

134
Q

Mary is 45 years old has been diagnosed by her APN with Osteoporosis. Mary is healthy female whose medical history only includes peptic ulcer disease. The APN includes which of the following in her teaching to Mary?

a. Mary doesn’t need drug therapy yet because she is only 45. b. Once osteoporosis is diagnosed and drug therapy is started, Mary will continue to take the medication for the rest of her life. c. The goals for drug therapy are minimizing bone loss, delaying the progression of osteoporosis, and reducing fractures and fracture related morbidity and mortality. d. Bisphosphonates are a good drug treatment option for Mary.

A

The answer is B. A. Mary will still need drug therapy even though she is 45 C. The goal for drug therapy is to PREVENT not reduce fractures D. Bisphosphonates are contraindicated in patients with a history of esophageal problems, gastritis, or peptic ulcer disease due to the adverse events including GI disturbance,esohpagitis, diarrhea, and abdominal pain.

135
Q

Lynn is a 58 year old postmenopausal woman who takes a PPI for history of gastric ulcers. Her ANP is discussing her risk for developing osteoporosis and recommends that Lynn begin taking what drug as a first line choice to help in the
prevention of osteoporosis?

a. Calcium Carbonate b. Calcium citrate c. Calcitonin d. Bisphosphonates

A

The answer is B.
A. Calcium Carbonate needs to be taken with food because acid is needed for maximal absorption. It will not be absorbed as well due to Lynn’s PPI use decreasing her gastric
acid production. B. Calcium Citrate is better absorbed and may be preferred by patients with reduced gastric acid production or high gastric pH because it does not require acid for absorption. C. Calcitonin balances parathyroid hormone, but is not a first choice drug for the PREVENTION of osteoporosis. D. Cautious Bisphosphonate use is recommended for patients with GI disorders.

136
Q

Which patient diagnosed with osteoporosis could be prescribed Raloxifene, a Selective Estrogen Receptor Modulator (SERM)?

a. Mary, a 35 year old nursing mother. b. Josie, a 65 year old woman with a history of deep vein thrombosis two years ago. c. Chloe, a 45 year old woman requiring prolonged bed rest following back surgery (scheduled for tomorrow). d. Tonia, a 50 year old woman diagnosed hyperlipidemia.

A

The correct answer is d.
a. Lactation and pregnancy are both contraindications for SERM therapy b. SERMs are contraindicated in women who have a history of thromboembolic
events c. A patient needs to discontinue SERM use 72 hours before prolonged immobility d. Hyperlipidemia is not a contraindication. SERMs have the potential to decrease total cholesterol and LDL levels.

137
Q

Mr P has osteoporosis, which of the following risk factors could have contributed to his diagnosis?

a. Light body frame, sedentary lifestyle, cigarette smoking, family history of
osteoporosis b. High sodium diet, daily exercise, GERD, insomnia c. African american, obesity, high vitamin D intake d. Daily exercise, heart disease, high calcium intake, frequent urination

A
The answer is A.
 According to the Pharmacotherapeutics for Advanced Practice class text pg. 986, table “Risk Factors”  B. is incorrect because sedentary lifestyle is a risk factor  C is incorrect because risk factors include Race:white, asian, native american/indian  D. is incorrect because low calcium intake is a risk factor
138
Q

Mrs. D has been treating her osteoporosis with Fosamax as well as calcium and vitamin D supplements for 2 years. Per the treatment algorithm for osteoporosis Mrs. D is due for a repeat DEXA scan. The NP should instruct that patient that if the DEXA scan is improved or the same:

a. The patient should anticipate discontinuing all treatment b. Continuing therapy c. Adding hormone modifiers to current treatment d. Adding Calcitonin to current treatment

A

The answer is B
According to the Pharmacotherapeutics for Advanced Practice class text pg. 991, figure 57.1 “Treatment algorithm for osteoporosis”
A. Discontinuing all treatment is not an option per the algorithm. C. The patient should only add hormone modifiers if the DEXA scan is worsened
D. Calcitonin is a hormone modifier- see rationale for option C.

139
Q

Which of the following is NOT a first-line therapy for osteoporosis?

A. Raloxifene
B. Bisphosphate therapy C. Calcitonin D. Calcium

A

The answer is C.
Pharmacotherapeutics for Advanced Practice: A Practical Approach
A. Raloxifene is a first-line therapy for prevention B. Bisphosphonates are a first-line therapy for prevention and treatment C. Calcitonin is a second-line therapy for osteoporosis D. During first-line therapy, patients should have calcium and vitamin D supplementation